1368488
2018
1
heidelberg-university-faculty-of-medicine
50
creator
asc
year
1
194
https://cnrmyrma.fr/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%2274P86KSE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ahmad%20et%20al.%22%2C%22parsedDate%22%3A%222018-09-08%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAhmad%2C%20N.%2C%20Ahuja%2C%20S.%20D.%2C%20Akkerman%2C%20O.%20W.%2C%20Alffenaar%2C%20J.-W.%20C.%2C%20Anderson%2C%20L.%20F.%2C%20Baghaei%2C%20P.%2C%20Bang%2C%20D.%2C%20Barry%2C%20P.%20M.%2C%20Bastos%2C%20M.%20L.%2C%20Behera%2C%20D.%2C%20Benedetti%2C%20A.%2C%20Bisson%2C%20G.%20P.%2C%20Boeree%2C%20M.%20J.%2C%20Bonnet%2C%20M.%2C%20Brode%2C%20S.%20K.%2C%20Brust%2C%20J.%20C.%20M.%2C%20Cai%2C%20Y.%2C%20Caumes%2C%20E.%2C%20Cegielski%2C%20J.%20P.%2C%20Centis%2C%20R.%2C%20Chan%2C%20P.-C.%2C%20Chan%2C%20E.%20D.%2C%20Chang%2C%20K.-C.%2C%20Charles%2C%20M.%2C%20Cirule%2C%20A.%2C%20Dalcolmo%2C%20M.%20P.%2C%20D%26%23x2019%3BAmbrosio%2C%20L.%2C%20de%20Vries%2C%20G.%2C%20Dheda%2C%20K.%2C%20Esmail%2C%20A.%2C%20Flood%2C%20J.%2C%20Fox%2C%20G.%20J.%2C%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%2C%20Fregona%2C%20G.%2C%20Gayoso%2C%20R.%2C%20Gegia%2C%20M.%2C%20Gler%2C%20M.%20T.%2C%20Gu%2C%20S.%2C%20Guglielmetti%2C%20L.%2C%20Holtz%2C%20T.%20H.%2C%20Hughes%2C%20J.%2C%20Isaakidis%2C%20P.%2C%20Jarlsberg%2C%20L.%2C%20Kempker%2C%20R.%20R.%2C%20Keshavjee%2C%20S.%2C%20Khan%2C%20F.%20A.%2C%20Kipiani%2C%20M.%2C%20Koenig%2C%20S.%20P.%2C%20Koh%2C%20W.-J.%2C%20Kritski%2C%20A.%2C%20Kuksa%2C%20L.%2C%20Kvasnovsky%2C%20C.%20L.%2C%20Kwak%2C%20N.%2C%20Lan%2C%20Z.%2C%20Lange%2C%20C.%2C%20Laniado-Labor%26%23xED%3Bn%2C%20R.%2C%20Lee%2C%20M.%2C%20Leimane%2C%20V.%2C%20Leung%2C%20C.-C.%2C%20Leung%2C%20E.%20C.-C.%2C%20Li%2C%20P.%20Z.%2C%20Lowenthal%2C%20P.%2C%20Maciel%2C%20E.%20L.%2C%20Marks%2C%20S.%20M.%2C%20Mase%2C%20S.%2C%20Mbuagbaw%2C%20L.%2C%20Migliori%2C%20G.%20B.%2C%20Milanov%2C%20V.%2C%20Miller%2C%20A.%20C.%2C%20Mitnick%2C%20C.%20D.%2C%20Modongo%2C%20C.%2C%20Mohr%2C%20E.%2C%20Monedero%2C%20I.%2C%20Nahid%2C%20P.%2C%20Ndjeka%2C%20N.%2C%20O%26%23x2019%3BDonnell%2C%20M.%20R.%2C%20Padayatchi%2C%20N.%2C%20Palmero%2C%20D.%2C%20Pape%2C%20J.%20W.%2C%20Podewils%2C%20L.%20J.%2C%20Reynolds%2C%20I.%2C%20Riekstina%2C%20V.%2C%20Robert%2C%20J.%2C%20Rodriguez%2C%20M.%2C%20Seaworth%2C%20B.%2C%20Seung%2C%20K.%20J.%2C%20Schnippel%2C%20K.%2C%20Shim%2C%20T.%20S.%2C%20Singla%2C%20R.%2C%20Smith%2C%20S.%20E.%2C%20Sotgiu%2C%20G.%2C%20Sukhbaatar%2C%20G.%2C%20Tabarsi%2C%20P.%2C%20Tiberi%2C%20S.%2C%20Trajman%2C%20A.%2C%20Trieu%2C%20L.%2C%20Udwadia%2C%20Z.%20F.%2C%20van%20der%20Werf%2C%20T.%20S.%2C%20Veziris%2C%20N.%2C%20Viiklepp%2C%20P.%2C%20Vilbrun%2C%20S.%20C.%2C%20Walsh%2C%20K.%2C%20Westenhouse%2C%20J.%2C%20Yew%2C%20W.-W.%2C%20Yim%2C%20J.-J.%2C%20Zetola%2C%20N.%20M.%2C%20Zignol%2C%20M.%20and%20Menzies%2C%20D.%20%282018%29.%20%26lt%3Bb%26gt%3BTreatment%20correlates%20of%20successful%20outcomes%20in%20pulmonary%20multidrug-resistant%20tuberculosis%3A%20an%20individual%20patient%20data%20meta-analysis%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20%26lt%3Bi%26gt%3B392%26lt%3B%5C%2Fi%26gt%3B%2C%20821%26%23x2013%3B834%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2818%2931644-1%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2818%2931644-1%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20correlates%20of%20successful%20outcomes%20in%20pulmonary%20multidrug-resistant%20tuberculosis%3A%20an%20individual%20patient%20data%20meta-analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nafees%22%2C%22lastName%22%3A%22Ahmad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shama%20D%22%2C%22lastName%22%3A%22Ahuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Onno%20W%22%2C%22lastName%22%3A%22Akkerman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jan-Willem%20C%22%2C%22lastName%22%3A%22Alffenaar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20F%22%2C%22lastName%22%3A%22Anderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Parvaneh%22%2C%22lastName%22%3A%22Baghaei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didi%22%2C%22lastName%22%3A%22Bang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pennan%20M%22%2C%22lastName%22%3A%22Barry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mayara%20L%22%2C%22lastName%22%3A%22Bastos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Digamber%22%2C%22lastName%22%3A%22Behera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrea%22%2C%22lastName%22%3A%22Benedetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20P%22%2C%22lastName%22%3A%22Bisson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20J%22%2C%22lastName%22%3A%22Boeree%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maryline%22%2C%22lastName%22%3A%22Bonnet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20K%22%2C%22lastName%22%3A%22Brode%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20C%20M%22%2C%22lastName%22%3A%22Brust%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ying%22%2C%22lastName%22%3A%22Cai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%20Peter%22%2C%22lastName%22%3A%22Cegielski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosella%22%2C%22lastName%22%3A%22Centis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pei-Chun%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%20D%22%2C%22lastName%22%3A%22Chan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwok-Chiu%22%2C%22lastName%22%3A%22Chang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Macarthur%22%2C%22lastName%22%3A%22Charles%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andra%22%2C%22lastName%22%3A%22Cirule%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margareth%20Pretti%22%2C%22lastName%22%3A%22Dalcolmo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lia%22%2C%22lastName%22%3A%22D%27Ambrosio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerard%22%2C%22lastName%22%3A%22de%20Vries%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keertan%22%2C%22lastName%22%3A%22Dheda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aliasgar%22%2C%22lastName%22%3A%22Esmail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Flood%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gregory%20J%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geisa%22%2C%22lastName%22%3A%22Fregona%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Gayoso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Medea%22%2C%22lastName%22%3A%22Gegia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Tarcela%22%2C%22lastName%22%3A%22Gler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sue%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20H%22%2C%22lastName%22%3A%22Holtz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jennifer%22%2C%22lastName%22%3A%22Hughes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petros%22%2C%22lastName%22%3A%22Isaakidis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leah%22%2C%22lastName%22%3A%22Jarlsberg%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Russell%20R%22%2C%22lastName%22%3A%22Kempker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salmaan%22%2C%22lastName%22%3A%22Keshavjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiz%20Ahmad%22%2C%22lastName%22%3A%22Khan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maia%22%2C%22lastName%22%3A%22Kipiani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Serena%20P%22%2C%22lastName%22%3A%22Koenig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Jung%22%2C%22lastName%22%3A%22Koh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Afranio%22%2C%22lastName%22%3A%22Kritski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charlotte%20L%22%2C%22lastName%22%3A%22Kvasnovsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nakwon%22%2C%22lastName%22%3A%22Kwak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhiyi%22%2C%22lastName%22%3A%22Lan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rafael%22%2C%22lastName%22%3A%22Laniado-Labor%5Cu00edn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Myungsun%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vaira%22%2C%22lastName%22%3A%22Leimane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chi-Chiu%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%20Chung-Ching%22%2C%22lastName%22%3A%22Leung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pei%20Zhi%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phil%22%2C%22lastName%22%3A%22Lowenthal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ethel%20L%22%2C%22lastName%22%3A%22Maciel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Suzanne%20M%22%2C%22lastName%22%3A%22Marks%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sundari%22%2C%22lastName%22%3A%22Mase%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lawrence%22%2C%22lastName%22%3A%22Mbuagbaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%20B%22%2C%22lastName%22%3A%22Migliori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vladimir%22%2C%22lastName%22%3A%22Milanov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ann%20C%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Carole%20D%22%2C%22lastName%22%3A%22Mitnick%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chawangwa%22%2C%22lastName%22%3A%22Modongo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erika%22%2C%22lastName%22%3A%22Mohr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ignacio%22%2C%22lastName%22%3A%22Monedero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Nahid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norbert%22%2C%22lastName%22%3A%22Ndjeka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%20R%22%2C%22lastName%22%3A%22O%27Donnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nesri%22%2C%22lastName%22%3A%22Padayatchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Domingo%22%2C%22lastName%22%3A%22Palmero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20William%22%2C%22lastName%22%3A%22Pape%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%20J%22%2C%22lastName%22%3A%22Podewils%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ian%22%2C%22lastName%22%3A%22Reynolds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vija%22%2C%22lastName%22%3A%22Riekstina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%22%2C%22lastName%22%3A%22Rodriguez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barbara%22%2C%22lastName%22%3A%22Seaworth%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kwonjune%20J%22%2C%22lastName%22%3A%22Seung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%22%2C%22lastName%22%3A%22Schnippel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tae%20Sun%22%2C%22lastName%22%3A%22Shim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupak%22%2C%22lastName%22%3A%22Singla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%20E%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giovanni%22%2C%22lastName%22%3A%22Sotgiu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ganzaya%22%2C%22lastName%22%3A%22Sukhbaatar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Payam%22%2C%22lastName%22%3A%22Tabarsi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anete%22%2C%22lastName%22%3A%22Trajman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lisa%22%2C%22lastName%22%3A%22Trieu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zarir%20F%22%2C%22lastName%22%3A%22Udwadia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tjip%20S%22%2C%22lastName%22%3A%22van%20der%20Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Piret%22%2C%22lastName%22%3A%22Viiklepp%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stalz%20Charles%22%2C%22lastName%22%3A%22Vilbrun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathleen%22%2C%22lastName%22%3A%22Walsh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Janice%22%2C%22lastName%22%3A%22Westenhouse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wing-Wai%22%2C%22lastName%22%3A%22Yew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae-Joon%22%2C%22lastName%22%3A%22Yim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicola%20M%22%2C%22lastName%22%3A%22Zetola%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matteo%22%2C%22lastName%22%3A%22Zignol%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%22%2C%22lastName%22%3A%22Menzies%22%7D%5D%2C%22abstractNote%22%3A%22Summary%5CnBackground%5CnTreatment%20outcomes%20for%20multidrug-resistant%20tuberculosis%20remain%20poor.%20We%20aimed%20to%20estimate%20the%20association%20of%20treatment%20success%20and%20death%20with%20the%20use%20of%20individual%20drugs%2C%20and%20the%20optimal%20number%20and%20duration%20of%20treatment%20with%20those%20drugs%20in%20patients%20with%20multidrug-resistant%20tuberculosis.%5CnMethods%5CnIn%20this%20individual%20patient%20data%20meta-analysis%2C%20we%20searched%20MEDLINE%2C%20Embase%2C%20and%20the%20Cochrane%20Library%20to%20identify%20potentially%20eligible%20observational%20and%20experimental%20studies%20published%20between%20Jan%201%2C%202009%2C%20and%20April%2030%2C%202016.%20We%20also%20searched%20reference%20lists%20from%20all%20systematic%20reviews%20of%20treatment%20of%20multidrug-resistant%20tuberculosis%20published%20since%202009.%20To%20be%20eligible%2C%20studies%20had%20to%20report%20original%20results%2C%20with%20end%20of%20treatment%20outcomes%20%28treatment%20completion%20%5Bsuccess%5D%2C%20failure%2C%20or%20relapse%29%20in%20cohorts%20of%20at%20least%2025%20adults%20%28aged%20%26gt%3B18%20years%29.%20We%20used%20anonymised%20individual%20patient%20data%20from%20eligible%20studies%2C%20provided%20by%20study%20investigators%2C%20regarding%20clinical%20characteristics%2C%20treatment%2C%20and%20outcomes.%20Using%20propensity%20score-matched%20generalised%20mixed%20effects%20logistic%2C%20or%20linear%20regression%2C%20we%20calculated%20adjusted%20odds%20ratios%20and%20adjusted%20risk%20differences%20for%20success%20or%20death%20during%20treatment%2C%20for%20specific%20drugs%20currently%20used%20to%20treat%20multidrug-resistant%20tuberculosis%2C%20as%20well%20as%20the%20number%20of%20drugs%20used%20and%20treatment%20duration.%5CnFindings%5CnOf%2012%5Cu2008030%20patients%20from%2025%20countries%20in%2050%20studies%2C%207346%20%2861%25%29%20had%20treatment%20success%2C%201017%20%288%25%29%20had%20failure%20or%20relapse%2C%20and%201729%20%2814%25%29%20died.%20Compared%20with%20failure%20or%20relapse%2C%20treatment%20success%20was%20positively%20associated%20with%20the%20use%20of%20linezolid%20%28adjusted%20risk%20difference%200%5Cu00b715%2C%2095%25%20CI%200%5Cu00b711%20to%200%5Cu00b718%29%2C%20levofloxacin%20%280%5Cu00b715%2C%200%5Cu00b713%20to%200%5Cu00b718%29%2C%20carbapenems%20%280%5Cu00b714%2C%200%5Cu00b706%20to%200%5Cu00b721%29%2C%20moxifloxacin%20%280%5Cu00b711%2C%200%5Cu00b708%20to%200%5Cu00b714%29%2C%20bedaquiline%20%280%5Cu00b710%2C%200%5Cu00b705%20to%200%5Cu00b714%29%2C%20and%20clofazimine%20%280%5Cu00b706%2C%200%5Cu00b701%20to%200%5Cu00b710%29.%20There%20was%20a%20significant%20association%20between%20reduced%20mortality%20and%20use%20of%20linezolid%20%28%5Cu20130%5Cu00b720%2C%20%5Cu20130%5Cu00b723%20to%20%5Cu20130%5Cu00b716%29%2C%20levofloxacin%20%28%5Cu20130%5Cu00b706%2C%20%5Cu20130%5Cu00b709%20to%20%5Cu20130%5Cu00b704%29%2C%20moxifloxacin%20%28%5Cu20130%5Cu00b707%2C%20%5Cu20130%5Cu00b710%20to%20%5Cu20130%5Cu00b704%29%2C%20or%20bedaquiline%20%28%5Cu20130%5Cu00b714%2C%20%5Cu20130%5Cu00b719%20to%20%5Cu20130%5Cu00b710%29.%20Compared%20with%20regimens%20without%20any%20injectable%20drug%2C%20amikacin%20provided%20modest%20benefits%2C%20but%20kanamycin%20and%20capreomycin%20were%20associated%20with%20worse%20outcomes.%20The%20remaining%20drugs%20were%20associated%20with%20slight%20or%20no%20improvements%20in%20outcomes.%20Treatment%20outcomes%20were%20significantly%20worse%20for%20most%20drugs%20if%20they%20were%20used%20despite%20in-vitro%20resistance.%20The%20optimal%20number%20of%20effective%20drugs%20seemed%20to%20be%20five%20in%20the%20initial%20phase%2C%20and%20four%20in%20the%20continuation%20phase.%20In%20these%20adjusted%20analyses%2C%20heterogeneity%2C%20based%20on%20a%20simulated%20I2%20method%2C%20was%20high%20for%20approximately%20half%20the%20estimates%20for%20specific%20drugs%2C%20although%20relatively%20low%20for%20number%20of%20drugs%20and%20durations%20analyses.%5CnInterpretation%5CnAlthough%20inferences%20are%20limited%20by%20the%20observational%20nature%20of%20these%20data%2C%20treatment%20outcomes%20were%20significantly%20better%20with%20use%20of%20linezolid%2C%20later%20generation%20fluoroquinolones%2C%20bedaquiline%2C%20clofazimine%2C%20and%20carbapenems%20for%20treatment%20of%20multidrug-resistant%20tuberculosis.%20These%20findings%20emphasise%20the%20need%20for%20trials%20to%20ascertain%20the%20optimal%20combination%20and%20duration%20of%20these%20drugs%20for%20treatment%20of%20this%20condition.%5CnFunding%5CnAmerican%20Thoracic%20Society%2C%20Canadian%20Institutes%20of%20Health%20Research%2C%20US%20Centers%20for%20Disease%20Control%20and%20Prevention%2C%20European%20Respiratory%20Society%2C%20Infectious%20Diseases%20Society%20of%20America.%22%2C%22date%22%3A%22September%208%2C%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS0140-6736%2818%2931644-1%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0140673618316441%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220140-6736%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T16%3A28%3A44Z%22%7D%7D%2C%7B%22key%22%3A%227YB8RPC5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ates%20et%20al.%22%2C%22parsedDate%22%3A%222018-07-13%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BAtes%2C%20L.%20S.%2C%20Dippenaar%2C%20A.%2C%20Sayes%2C%20F.%2C%20Pawlik%2C%20A.%2C%20Bouchier%2C%20C.%2C%20Ma%2C%20L.%2C%20Warren%2C%20R.%20M.%2C%20Sougakoff%2C%20W.%2C%20Majlessi%2C%20L.%2C%20van%20Heijst%2C%20J.%20W.%20J.%2C%20Brossier%2C%20F.%20and%20Brosch%2C%20R.%20%282018%29.%20%26lt%3Bb%26gt%3BUnexpected%20Genomic%20and%20Phenotypic%20Diversity%20of%20Mycobacterium%20africanum%20Lineage%205%20Affects%20Drug%20Resistance%2C%20Protein%20Secretion%2C%20and%20Immunogenicity%26lt%3B%5C%2Fb%26gt%3B.%20Genome%20Biol%20Evol%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%201858%26%23x2013%3B1874%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fgbe%5C%2Fevy145%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1093%5C%2Fgbe%5C%2Fevy145%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Unexpected%20Genomic%20and%20Phenotypic%20Diversity%20of%20Mycobacterium%20africanum%20Lineage%205%20Affects%20Drug%20Resistance%2C%20Protein%20Secretion%2C%20and%20Immunogenicity%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20S%22%2C%22lastName%22%3A%22Ates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anzaan%22%2C%22lastName%22%3A%22Dippenaar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadel%22%2C%22lastName%22%3A%22Sayes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Pawlik%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiane%22%2C%22lastName%22%3A%22Bouchier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurence%22%2C%22lastName%22%3A%22Ma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robin%20M%22%2C%22lastName%22%3A%22Warren%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laleh%22%2C%22lastName%22%3A%22Majlessi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeroen%20W%20J%22%2C%22lastName%22%3A%22van%20Heijst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Brosch%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20africanum%20consists%20of%20Lineages%20L5%20and%20L6%20of%20the%20Mycobacterium%20tuberculosis%20complex%20%28MTBC%29%20and%20causes%20human%20tuberculosis%20in%20specific%20regions%20of%20Western%20Africa%2C%20but%20is%20generally%20not%20transmitted%20in%20other%20parts%20of%20the%20world.%20Since%20M.%20africanum%20is%20evolutionarily%20closely%20placed%20between%20the%20globally%20dispersed%20Mycobacterium%20tuberculosis%20and%20animal-adapted%20MTBC-members%2C%20these%20lineages%20provide%20valuable%20insight%20into%20M.%20tuberculosis%20evolution.%20Here%2C%20we%20have%20collected%2015%20M.%20africanum%20L5%20strains%20isolated%20in%20France%20over%204%20decades.%20Illumina%20sequencing%20and%20phylogenomic%20analysis%20revealed%20a%20previously%20underappreciated%20diversity%20within%20L5%2C%20which%20consists%20of%20distinct%20sublineages.%20L5%20strains%20caused%20relatively%20high%20levels%20of%20extrapulmonary%20tuberculosis%20and%20included%20multi-%20and%20extensively%20drug-resistant%20isolates%2C%20especially%20in%20the%20newly%20defined%20sublineage%20L5.2.%20The%20specific%20L5%20sublineages%20also%20exhibit%20distinct%20phenotypic%20characteristics%20related%20to%20in%20vitro%20growth%2C%20protein%20secretion%20and%20in%20vivo%20immunogenicity.%20In%20particular%2C%20we%20identified%20a%20PE_PGRS%20and%20PPE-MPTR%20secretion%20defect%20specific%20for%20sublineage%20L5.2%2C%20which%20was%20independent%20of%20PPE38.%20Furthermore%2C%20L5%20isolates%20were%20able%20to%20efficiently%20secrete%20and%20induce%20immune%20responses%20against%20ESX-1%20substrates%20contrary%20to%20previous%20predictions.%20These%20phenotypes%20of%20Type%20VII%20protein%20secretion%20and%20immunogenicity%20provide%20valuable%20information%20to%20better%20link%20genome%20sequences%20to%20phenotypic%20traits%20and%20thereby%20understand%20the%20evolution%20of%20the%20MTBC.%22%2C%22date%22%3A%222018-7-13%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1093%5C%2Fgbe%5C%2Fevy145%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC6071665%5C%2F%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221759-6653%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T08%3A34%3A53Z%22%7D%7D%2C%7B%22key%22%3A%22LMYL4GXD%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bastard%20et%20al.%22%2C%22parsedDate%22%3A%222018-07-03%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBastard%2C%20M.%2C%20Guglielmetti%2C%20L.%2C%20Huerga%2C%20H.%2C%20Hayrapetyan%2C%20A.%2C%20Khachatryan%2C%20N.%2C%20Yegiazaryan%2C%20L.%2C%20Faqirzai%2C%20J.%2C%20Hovhannisyan%2C%20L.%2C%20Varaine%2C%20F.%20and%20Hewison%2C%20C.%20%282018%29.%20%26lt%3Bb%26gt%3BBedaquiline%20and%20Repurposed%20Drugs%20for%20Fluoroquinolone-Resistant%20Multidrug-Resistant%20Tuberculosis%3A%20How%20Much%20Better%20Are%20They%3F%26lt%3B%5C%2Fb%26gt%3B%20Am%20J%20Respir%20Crit%20Care%20Med%20%26lt%3Bi%26gt%3B198%26lt%3B%5C%2Fi%26gt%3B%2C%201228%26%23x2013%3B1231%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1164%5C%2Frccm.201801-0019LE%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1164%5C%2Frccm.201801-0019LE%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bedaquiline%20and%20Repurposed%20Drugs%20for%20Fluoroquinolone-Resistant%20Multidrug-Resistant%20Tuberculosis%3A%20How%20Much%20Better%20Are%20They%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathieu%22%2C%22lastName%22%3A%22Bastard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Helena%22%2C%22lastName%22%3A%22Huerga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armen%22%2C%22lastName%22%3A%22Hayrapetyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naira%22%2C%22lastName%22%3A%22Khachatryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lusine%22%2C%22lastName%22%3A%22Yegiazaryan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jamil%22%2C%22lastName%22%3A%22Faqirzai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lana%22%2C%22lastName%22%3A%22Hovhannisyan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francis%22%2C%22lastName%22%3A%22Varaine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Hewison%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22July%203%2C%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1164%5C%2Frccm.201801-0019LE%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.atsjournals.org%5C%2Fdoi%5C%2Ffull%5C%2F10.1164%5C%2Frccm.201801-0019LE%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221073-449X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-05T15%3A02%3A58Z%22%7D%7D%2C%7B%22key%22%3A%226PHPLBI2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bergot%20et%20al.%22%2C%22parsedDate%22%3A%222018-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBergot%2C%20E.%2C%20Abiteboul%2C%20D.%2C%20Andr%26%23xE9%3Bjak%2C%20C.%2C%20Antoun%2C%20F.%2C%20Barras%2C%20E.%2C%20Blanc%2C%20F.-X.%2C%20Bourgarit%2C%20A.%2C%20Charlois-Ou%2C%20C.%2C%20Delacourt%2C%20C.%2C%20Dirou%2C%20S.%2C%20Gerin%2C%20M.%2C%20Guerin%2C%20S.%2C%20Haustraete%2C%20%26%23xC9%3B.%2C%20Henry%2C%20B.%2C%20Lucet%2C%20J.-C.%2C%20Maitre%2C%20T.%2C%20Morin%2C%20J.%2C%20Le%20Palud%2C%20P.%2C%20Pommelet%2C%20V.%2C%20Rivoisy%2C%20C.%2C%20Robert%2C%20J.%2C%20Veziris%2C%20N.%20and%20Herrmann%2C%20J.-L.%20%282018%29.%20%26lt%3Bb%26gt%3B%5BPractice%20recommendations%20for%20the%20use%20and%20interpretation%20of%20interferon%20gamma%20release%20assays%20in%20the%20diagnosis%20of%20latent%20and%20active%20tuberculosis%5D%26lt%3B%5C%2Fb%26gt%3B.%20Rev%20Mal%20Respir%20%26lt%3Bi%26gt%3B35%26lt%3B%5C%2Fi%26gt%3B%2C%20852%26%23x2013%3B858%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2018.08.007%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2018.08.007%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5BPractice%20recommendations%20for%20the%20use%20and%20interpretation%20of%20interferon%20gamma%20release%20assays%20in%20the%20diagnosis%20of%20latent%20and%20active%20tuberculosis%5D%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Bergot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Abiteboul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Andr%5Cu00e9jak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Antoun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Barras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.-X.%22%2C%22lastName%22%3A%22Blanc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bourgarit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Charlois-Ou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Delacourt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Dirou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Gerin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Guerin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%5Cu00c9%22%2C%22lastName%22%3A%22Haustraete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Henry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-C.%22%2C%22lastName%22%3A%22Lucet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T.%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Morin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Le%20Palud%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Pommelet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Rivoisy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.-L.%22%2C%22lastName%22%3A%22Herrmann%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Oct%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2018.08.007%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221776-2588%22%2C%22language%22%3A%22fre%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A38%3A06Z%22%7D%7D%2C%7B%22key%22%3A%22BQHF8JCW%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Blanc%20et%20al.%22%2C%22parsedDate%22%3A%222018-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BBlanc%2C%20F.-X.%2C%20Dirou%2C%20S.%2C%20Morin%2C%20J.%20and%20Veziris%2C%20N.%20%282018%29.%20%26lt%3Bb%26gt%3B%5BInterferon%20gamma%20release%20assay%20tests%20for%20the%20diagnosis%20of%20active%20tuberculosis%5D%26lt%3B%5C%2Fb%26gt%3B.%20Rev%20Mal%20Respir%20%26lt%3Bi%26gt%3B35%26lt%3B%5C%2Fi%26gt%3B%2C%20894%26%23x2013%3B899%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2018.08.016%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2018.08.016%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22%5BInterferon%20gamma%20release%20assay%20tests%20for%20the%20diagnosis%20of%20active%20tuberculosis%5D%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.-X.%22%2C%22lastName%22%3A%22Blanc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Dirou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Morin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Oct%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2018.08.016%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221776-2588%22%2C%22language%22%3A%22fre%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A37%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22Q5DCBVM4%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCambau%2C%20E.%20%282018%29.%20%26lt%3Bb%26gt%3BAntileprosy%20drugs%3A%20mode%20of%20action%20and%20mechanisms%26lt%3B%5C%2Fb%26gt%3B.%20In%3A%20%26lt%3Bb%26gt%3BInternational%20textbook%20of%20leprosy%26lt%3B%5C%2Fb%26gt%3B%2C%20URL%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Finternationaltextbookofleprosy.org%5C%2Fchapter%5C%2Fanti-leprosy-drugs-modes-action-and-mechanisms-resistance-mycobacterium-leprae%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Finternationaltextbookofleprosy.org%5C%2Fchapter%5C%2Fanti-leprosy-drugs-modes-action-and-mechanisms-resistance-mycobacterium-leprae%26lt%3B%5C%2Fa%26gt%3B%20%5BAccessed%20May%202022%5D.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Antileprosy%20drugs%3A%20mode%20of%20action%20and%20mechanisms%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22bookTitle%22%3A%22International%20textbook%20of%20leprosy%22%2C%22date%22%3A%222018%22%2C%22originalDate%22%3A%22%22%2C%22originalPublisher%22%3A%22%22%2C%22originalPlace%22%3A%22%22%2C%22format%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Finternationaltextbookofleprosy.org%5C%2Fchapter%5C%2Fanti-leprosy-drugs-modes-action-and-mechanisms-resistance-mycobacterium-leprae%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-05-16T15%3A24%3A51Z%22%7D%7D%2C%7B%22key%22%3A%225DABHW8P%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Cambau%20et%20al.%22%2C%22parsedDate%22%3A%222018-12-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCambau%2C%20E.%2C%20Saunderson%2C%20P.%2C%20Matsuoka%2C%20M.%2C%20Cole%2C%20S.%20T.%2C%20Kai%2C%20M.%2C%20Suffys%2C%20P.%2C%20Rosa%2C%20P.%20S.%2C%20Williams%2C%20D.%2C%20Gupta%2C%20U.%20D.%2C%20Lavania%2C%20M.%2C%20Cardona-Castro%2C%20N.%2C%20Miyamoto%2C%20Y.%2C%20Hagge%2C%20D.%2C%20Srikantam%2C%20A.%2C%20Hongseng%2C%20W.%2C%20Indropo%2C%20A.%2C%20Vissa%2C%20V.%2C%20Johnson%2C%20R.%20C.%2C%20Cauchoix%2C%20B.%2C%20Pannikar%2C%20V.%20K.%2C%20Cooreman%2C%20E.%20a.%20W.%20D.%2C%20Pemmaraju%2C%20V.%20R.%20R.%2C%20Gillini%2C%20L.%2C%20Kriswamati%2C%20A.%2C%20Al-Samie%2C%20A.%20R.%2C%20Issoufou%2C%20A.%2C%20Tiendrebeogo%2C%20A.%2C%20Kingalu%2C%20A.%2C%20Randrianantoandro%2C%20A.%2C%20Kumar%2C%20A.%2C%20Chauffour%2C%20A.%2C%20Win%2C%20A.%20A.%2C%20Pandey%2C%20B.%2C%20Agrawal%2C%20C.%20M.%2C%20Widaningrum%2C%20C.%2C%20Schmotzer%2C%20C.%2C%20Kafando%2C%20C.%2C%20Bhandari%2C%20C.%20M.%2C%20Sema%2C%20C.%2C%20Vidanagama%2C%20D.%20S.%2C%20Scollard%2C%20D.%20M.%2C%20Beyene%2C%20D.%2C%20Morelo%2C%20E.%20F.%2C%20Kassa%2C%20E.%20D.%2C%20Ramarolahy%2C%20E.%20B.%2C%20Claco%2C%20E.%2C%20Villalon%2C%20E.%20E.%2C%20Sidibe%2C%20F.%2C%20Sakho%2C%20F.%2C%20Abdoulaye%2C%20F.%2C%20Guilengue%2C%20F.%20F.%2C%20Gajete%2C%20F.%2C%20Babu%2C%20G.%20R.%2C%20Moussa%2C%20G.%2C%20Thakur%2C%20G.%20D.%2C%20Cabanos%2C%20G.%2C%20Sock%2C%20G.%2C%20Clugston%2C%20G.%2C%20Zaidy%2C%20H.%2C%20Watanabe%2C%20H.%2C%20Kawuma%2C%20H.%20J.%2C%20Mallari%2C%20I.%20B.%2C%20Goulart%2C%20I.%20M.%20B.%2C%20Ahamed%2C%20I.%2C%20Subbanna%2C%20J.%2C%20Houzeo%2C%20J.%20G.%2C%20Luengu%2C%20J.%20N.%20M.%2C%20Bertolli%2C%20J.%2C%20Lloyd-Owen%2C%20J.%2C%20Matheu%2C%20J.%2C%20Brunelli%2C%20J.%20P.%2C%20Alzate%2C%20J.%20C.%20B.%2C%20Neupane%2C%20Kapil%20Dev%2C%20Osuga%2C%20K.%2C%20Yamaguchi%2C%20K.%2C%20Azam%2C%20K.%2C%20Lin%2C%20K.%20M.%2C%20Momoudu%2C%20K.%2C%20Kyaw%2C%20K.%2C%20Bide%2C%20L.%2C%20Doanh%2C%20L.%20H.%2C%20My%2C%20L.%20H.%2C%20Shah%2C%20M.%2C%20Kodio%2C%20M.%2C%20Sidibe%2C%20M.%2C%20Ebenezer%2C%20M.%2C%20Grossi%2C%20M.%20A.%20de%20F.%2C%20Balagon%2C%20M.%20F.%2C%20Canlonon%2C%20M.%2C%20Makino%2C%20M.%2C%20Htoo%2C%20M.%20M.%2C%20Ahmed%2C%20M.%20J.%2C%20Nadine%2C%20M.-M.%2C%20Roferos%2C%20F.%20O.%2C%20Krismawati%2C%20H.%2C%20Thida%2C%20M.%2C%20Htoon%2C%20M.%20T.%2C%20Neupane%2C%20K.%20D.%2C%20Phuc%2C%20N.%20H.%20N.%2C%20Van%2C%20N.%20H.%2C%20Hai%2C%20N.%20P.%20N.%2C%20Ishii%2C%20N.%2C%20Soe%2C%20O.%2C%20Amiel%2C%20O.%2C%20Tossou%2C%20O.%2C%20Konare%2C%20O.%2C%20Joshi%2C%20P.%20L.%2C%20Rao%2C%20P.%20V.%20R.%2C%20Krishnamurthy%2C%20P.%2C%20Brennan%2C%20P.%20J.%2C%20Busso%2C%20P.%2C%20Bhatia%2C%20R.%2C%20Andrianarivelo%2C%20M.%20R.%2C%20Ramdas%2C%20D.%20R.%2C%20Chabi%2C%20R.%2C%20Gusmao%2C%20R.%2C%20DjupuriIzwardy%2C%20R.%2C%20Soares%2C%20R.%20C.%20F.%20R.%2C%20Jhadav%2C%20R.%2C%20Buhrer%2C%20S.%2C%20Cho%2C%20S.-N.%20R.%2C%20Jianping%2C%20S.%2C%20Lzumi%2C%20S.%2C%20Barua%2C%20S.%2C%20Chaitanya%2C%20S.%2C%20Tiendrebeogo%2C%20S.%20M.%20R.%2C%20Khang%2C%20T.%20H.%2C%20Gillis%2C%20T.%20P.%2C%20Mori%2C%20T.%2C%20Vijayalakshmi%2C%20V.%2C%20Kamara%2C%20V.%20D.%2C%20Wei%2C%20W.%2C%20Smith%2C%20W.%20C.%20S.%2C%20Li%2C%20W.%2C%20Lew%2C%20W.%2C%20Al-Qubati%2C%20Y.%2C%20Suzuki%2C%20Y.%20and%20Nanba%2C%20Y.%20%282018%29.%20%26lt%3Bb%26gt%3BAntimicrobial%20resistance%20in%20leprosy%3A%20results%20of%20the%20first%20prospective%20open%20survey%20conducted%20by%20a%20WHO%20surveillance%20network%20for%20the%20period%202009%26%23x2013%3B15%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%2C%201305%26%23x2013%3B1310%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2018.02.022%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2018.02.022%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Antimicrobial%20resistance%20in%20leprosy%3A%20results%20of%20the%20first%20prospective%20open%20survey%20conducted%20by%20a%20WHO%20surveillance%20network%20for%20the%20period%202009%5Cu201315%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Saunderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Matsuoka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%20T.%22%2C%22lastName%22%3A%22Cole%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Kai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%22%2C%22lastName%22%3A%22Suffys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20S.%22%2C%22lastName%22%3A%22Rosa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Williams%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22U.%20D.%22%2C%22lastName%22%3A%22Gupta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Lavania%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Cardona-Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Y.%22%2C%22lastName%22%3A%22Miyamoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%22%2C%22lastName%22%3A%22Hagge%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Srikantam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Hongseng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Indropo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Vissa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20C.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Cauchoix%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20K.%22%2C%22lastName%22%3A%22Pannikar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20a.%20W.%20D.%22%2C%22lastName%22%3A%22Cooreman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%20R.%20R.%22%2C%22lastName%22%3A%22Pemmaraju%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Gillini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Kriswamati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%20Rahim%22%2C%22lastName%22%3A%22Al-Samie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahamed%22%2C%22lastName%22%3A%22Issoufou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexandre%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22AmriMiraju%22%2C%22lastName%22%3A%22Kingalu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andriamira%22%2C%22lastName%22%3A%22Randrianantoandro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anil%22%2C%22lastName%22%3A%22Kumar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aurelie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aye%20Aye%22%2C%22lastName%22%3A%22Win%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basudev%22%2C%22lastName%22%3A%22Pandey%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%20M.%22%2C%22lastName%22%3A%22Agrawal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiana%22%2C%22lastName%22%3A%22Widaningrum%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Schmotzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christophe%22%2C%22lastName%22%3A%22Kafando%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chuda%20Mani%22%2C%22lastName%22%3A%22Bhandari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cynthia%22%2C%22lastName%22%3A%22Sema%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20S.%22%2C%22lastName%22%3A%22Vidanagama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Scollard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Demmissew%22%2C%22lastName%22%3A%22Beyene%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eliane%20Faria%22%2C%22lastName%22%3A%22Morelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elizabeth%20Dizaneh%22%2C%22lastName%22%3A%22Kassa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enerantien%20Benoit%22%2C%22lastName%22%3A%22Ramarolahy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Claco%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%20ES%22%2C%22lastName%22%3A%22Villalon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Famoussa%22%2C%22lastName%22%3A%22Sidibe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fatoumata%22%2C%22lastName%22%3A%22Sakho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fomba%22%2C%22lastName%22%3A%22Abdoulaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisco%20F.%22%2C%22lastName%22%3A%22Guilengue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fransesca%22%2C%22lastName%22%3A%22Gajete%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gadde%20Rajan%22%2C%22lastName%22%3A%22Babu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gado%22%2C%22lastName%22%3A%22Moussa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Garib%20Das%22%2C%22lastName%22%3A%22Thakur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gemma%22%2C%22lastName%22%3A%22Cabanos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gouressi%22%2C%22lastName%22%3A%22Sock%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Greame%22%2C%22lastName%22%3A%22Clugston%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hany%22%2C%22lastName%22%3A%22Zaidy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haruo%22%2C%22lastName%22%3A%22Watanabe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Herman%20Joseph%22%2C%22lastName%22%3A%22Kawuma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Irene%20Balenton%22%2C%22lastName%22%3A%22Mallari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Isabella%20Maria%20Bernandes%22%2C%22lastName%22%3A%22Goulart%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Issoufou%22%2C%22lastName%22%3A%22Ahamed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Subbanna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Gabin%22%2C%22lastName%22%3A%22Houzeo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Norbert%20Mputu%22%2C%22lastName%22%3A%22Luengu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeanne%22%2C%22lastName%22%3A%22Bertolli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Lloyd-Owen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Matheu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jos%5Cu00e9%20Pereira%22%2C%22lastName%22%3A%22Brunelli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Camilo%20Beltran%22%2C%22lastName%22%3A%22Alzate%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kapil%20Dev%22%2C%22lastName%22%3A%22Neupane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katsunori%22%2C%22lastName%22%3A%22Osuga%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kazuko%22%2C%22lastName%22%3A%22Yamaguchi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khalid%22%2C%22lastName%22%3A%22Azam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khin%20Maung%22%2C%22lastName%22%3A%22Lin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kodia%22%2C%22lastName%22%3A%22Momoudu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyaw%22%2C%22lastName%22%3A%22Kyaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Landry%22%2C%22lastName%22%3A%22Bide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Le%20Huu%22%2C%22lastName%22%3A%22Doanh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ley%20Huyen%22%2C%22lastName%22%3A%22My%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahesh%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mamadou%22%2C%22lastName%22%3A%22Kodio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mamadou%22%2C%22lastName%22%3A%22Sidibe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mannam%22%2C%22lastName%22%3A%22Ebenezer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maria%20Aparecida%20de%20Faria%22%2C%22lastName%22%3A%22Grossi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marivic%20F.%22%2C%22lastName%22%3A%22Balagon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marlience%22%2C%22lastName%22%3A%22Canlonon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Masahiko%22%2C%22lastName%22%3A%22Makino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Maung%20Maung%22%2C%22lastName%22%3A%22Htoo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Md%20Jamsheed%22%2C%22lastName%22%3A%22Ahmed%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mintsey-mi-Makuth%22%2C%22lastName%22%3A%22Nadine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florenda%20Orcullo%22%2C%22lastName%22%3A%22Roferos%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hana%22%2C%22lastName%22%3A%22Krismawati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%22%2C%22lastName%22%3A%22Thida%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Myo%20Thet%22%2C%22lastName%22%3A%22Htoon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22K.%20D.%22%2C%22lastName%22%3A%22Neupane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nhu%20Ha%20Nguyen%22%2C%22lastName%22%3A%22Phuc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22NguyenThi%20Hai%22%2C%22lastName%22%3A%22Van%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ngyuen%20Phuc%20Nhu%22%2C%22lastName%22%3A%22Hai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norisha%22%2C%22lastName%22%3A%22Ishii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oke%22%2C%22lastName%22%3A%22Soe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olga%22%2C%22lastName%22%3A%22Amiel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Omar%22%2C%22lastName%22%3A%22Tossou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ousmane%22%2C%22lastName%22%3A%22Konare%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20L.%22%2C%22lastName%22%3A%22Joshi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22P.%20V.%20Ranganadha%22%2C%22lastName%22%3A%22Rao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Padebettu%22%2C%22lastName%22%3A%22Krishnamurthy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20J.%22%2C%22lastName%22%3A%22Brennan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Phillipe%22%2C%22lastName%22%3A%22Busso%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajesh%22%2C%22lastName%22%3A%22Bhatia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mala%20Rakoto%22%2C%22lastName%22%3A%22Andrianarivelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20R.%22%2C%22lastName%22%3A%22Ramdas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raoul%22%2C%22lastName%22%3A%22Chabi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renato%22%2C%22lastName%22%3A%22Gusmao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rita%22%2C%22lastName%22%3A%22DjupuriIzwardy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rosa%20Castalia%20Franca%20Riberio%22%2C%22lastName%22%3A%22Soares%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rupendra%22%2C%22lastName%22%3A%22Jhadav%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samira%22%2C%22lastName%22%3A%22Buhrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sang-Nae%20Ray%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shen%22%2C%22lastName%22%3A%22Jianping%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shinzo%22%2C%22lastName%22%3A%22Lzumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sumana%22%2C%22lastName%22%3A%22Barua%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sundeep%22%2C%22lastName%22%3A%22Chaitanya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sylvestre%20Marie%20Roget%22%2C%22lastName%22%3A%22Tiendrebeogo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tan%20Hau%22%2C%22lastName%22%3A%22Khang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20P.%22%2C%22lastName%22%3A%22Gillis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Toru%22%2C%22lastName%22%3A%22Mori%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Vijayalakshmi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vedastus%20Deusdedit%22%2C%22lastName%22%3A%22Kamara%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wang%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Cairn%20S.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wei%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Woojin%22%2C%22lastName%22%3A%22Lew%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasin%22%2C%22lastName%22%3A%22Al-Qubati%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yasuhiko%22%2C%22lastName%22%3A%22Suzuki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yoshio%22%2C%22lastName%22%3A%22Nanba%22%7D%5D%2C%22abstractNote%22%3A%22%26lt%3Bh2%26gt%3BAbstract%26lt%3B%5C%2Fh2%26gt%3B%26lt%3Bh3%26gt%3BObjectives%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BAntimicrobial%20resistance%20%28AMR%29%20is%20a%20priority%20for%20surveillance%20in%20bacterial%20infections.%20For%20leprosy%2C%20AMR%20has%20not%20been%20assessed%20because%20%26lt%3Bi%26gt%3BMycobacterium%20leprae%26lt%3B%5C%2Fi%26gt%3B%20does%20not%20grow%20%26lt%3Bi%26gt%3Bin%20vitro%26lt%3B%5C%2Fi%26gt%3B.%20We%20aim%20to%20obtain%20AMR%20data%20using%20molecular%20detection%20of%20resistance%20genes%20and%20to%20conduct%20a%20prospective%20open%20survey%20of%20resistance%20to%20antileprosy%20drugs%20in%20countries%20where%20leprosy%20is%20endemic%20through%20a%20WHO%20surveillance%20network.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BMethods%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BFrom%202009%20to%202015%2C%20multi-bacillary%20leprosy%20cases%20at%20sentinel%20sites%20of%2019%20countries%20were%20studied%20for%20resistance%20to%20rifampicin%2C%20dapsone%20and%20ofloxacin%20by%20PCR%20sequencing%20of%20the%20drug-resistance-determining%20regions%20of%20the%20genes%20%26lt%3Bi%26gt%3BrpoB%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3BfolP1%26lt%3B%5C%2Fi%26gt%3B%20and%20%26lt%3Bi%26gt%3BgyrA%26lt%3B%5C%2Fi%26gt%3B.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BResults%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BAmong%201932%20%281143%20relapse%20and%20789%20new%29%20cases%20studied%2C%20154%20%288.0%25%29%20%26lt%3Bi%26gt%3BM.%20leprae%26lt%3B%5C%2Fi%26gt%3B%20strains%20were%20found%20with%20mutations%20conferring%20resistance%20showing%20182%20resistance%20traits%20%2874%20for%20rifampicin%2C%2087%20for%20dapsone%20and%2021%20for%20ofloxacin%29.%20Twenty%20cases%20showed%20rifampicin%20and%20dapsone%20resistance%2C%20four%20showed%20ofloxacin%20and%20dapsone%20resistance%2C%20but%20no%20cases%20were%20resistant%20to%20rifampicin%20and%20ofloxacin.%20Rifampicin%20resistance%20was%20observed%20among%20relapse%20%2858%5C%2F1143%2C%205.1%25%29%20and%20new%20%2816%5C%2F789%2C%202.0%25%29%20cases%20in%2012%20countries.%20India%2C%20Brazil%20and%20Colombia%20reported%20more%20than%20five%20rifampicin-resistant%20cases.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BConclusions%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BThis%20is%20the%20first%20study%20reporting%20global%20data%20on%20AMR%20in%20leprosy.%20Rifampicin%20resistance%20emerged%2C%20stressing%20the%20need%20for%20expansion%20of%20surveillance.%20This%20is%20also%20a%20call%20for%20vigilance%20on%20the%20global%20use%20of%20antimicrobial%20agents%2C%20because%20ofloxacin%20resistance%20probably%20developed%20in%20relation%20to%20the%20general%20intake%20of%20antibiotics%20for%20other%20infections%20as%20it%20is%20not%20part%20of%20the%20multidrug%20combination%20used%20to%20treat%20leprosy.%26lt%3B%5C%2Fp%26gt%3B%22%2C%22date%22%3A%222018%5C%2F12%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2018.02.022%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2818%2930197-6%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A28%3A25Z%22%7D%7D%2C%7B%22key%22%3A%22XJTY4VYG%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Chauffour%20et%20al.%22%2C%22parsedDate%22%3A%222018-11-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BChauffour%2C%20A.%2C%20Lecorche%2C%20E.%2C%20Reibel%2C%20F.%2C%20Mougari%2C%20F.%2C%20Raskine%2C%20L.%2C%20Aubry%2C%20A.%2C%20Jarlier%2C%20V.%20and%20Cambau%2C%20E.%20%282018%29.%20%26lt%3Bb%26gt%3BProspective%20study%20on%20antimicrobial%20resistance%20in%20leprosy%20cases%20diagnosed%20in%20France%20from%202001%20to%202015%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%2C%201213.e5-1213.e8%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2018.06.004%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2018.06.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Prospective%20study%20on%20antimicrobial%20resistance%20in%20leprosy%20cases%20diagnosed%20in%20France%20from%202001%20to%202015%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Lecorche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Reibel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222018-11-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2018.06.004%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2818%2930463-4%5C%2Ffulltext%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T08%3A27%3A34Z%22%7D%7D%2C%7B%22key%22%3A%222L3QBFXB%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Coolen-Allou%20et%20al.%22%2C%22parsedDate%22%3A%222018-07-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BCoolen-Allou%2C%20N.%2C%20Touron%2C%20T.%2C%20Belmonte%2C%20O.%2C%20Gazaille%2C%20V.%2C%20Andre%2C%20M.%2C%20Allyn%2C%20J.%2C%20Picot%2C%20S.%2C%20Payet%2C%20A.%20and%20Veziris%2C%20N.%20%282018%29.%20%26lt%3Bb%26gt%3BClinical%2C%20Radiological%2C%20and%20Microbiological%20Characteristics%20of%20Mycobacterium%20simiae%20Infection%20in%2097%20Patients%26lt%3B%5C%2Fb%26gt%3B.%20Antimicrobial%20Agents%20and%20Chemotherapy%20%26lt%3Bi%26gt%3B62%26lt%3B%5C%2Fi%26gt%3B%2C%20e00395-18%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00395-18%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1128%5C%2FAAC.00395-18%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%2C%20Radiological%2C%20and%20Microbiological%20Characteristics%20of%20Mycobacterium%20simiae%20Infection%20in%2097%20Patients%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Coolen-Allou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%22%2C%22lastName%22%3A%22Touron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Olivier%22%2C%22lastName%22%3A%22Belmonte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Virgile%22%2C%22lastName%22%3A%22Gazaille%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michel%22%2C%22lastName%22%3A%22Andre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Allyn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sandrine%22%2C%22lastName%22%3A%22Picot%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Annabelle%22%2C%22lastName%22%3A%22Payet%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20simiae%20is%20a%20rare%20species%20of%20slow-growing%20nontuberculous%20mycobacteria%20%28NTM%29.%20From%202002%20to%202017%2C%20we%20conducted%20a%20retrospective%20study%20that%20included%20all%20patients%20with%20NTM-positive%20respiratory%20samples%20detected%20in%20two%20university%20hospitals%20of%20the%20French%20overseas%20department%20of%20Reunion%20Island.%20We%20recorded%20the%20prevalence%20of%20M.%20simiae%20in%20this%20cohort%2C%20as%20well%20as%20the%20clinical%2C%20radiological%2C%20and%20microbiological%20features%20of%20patients%20with%20at%20least%201%20sample%20positive%20for%20M.%20simiae.%20In%20our%20cohort%2C%2097%20patients%20%2815.1%25%29%20were%20positive%20for%20M.%20simiae.%20Twenty-one%20patients%20%2821.6%25%29%20met%20the%20American%20Thoracic%20Society%20%28ATS%29%20criteria%20for%20infection.%20M.%20simiae%20infection%20was%20associated%20with%20bronchiectasis%2C%20micronodular%20lesions%2C%20and%20weight%20loss.%20Antibiotic%20susceptibility%20testing%20was%20performed%20for%2060%20patients%2C%20and%20the%20isolates%20were%20found%20to%20have%20low%20susceptibility%20to%20antibiotics%2C%20except%20for%20amikacin%2C%20fluoroquinolones%2C%20and%20clarithromycin.%20Treatment%20failed%20for%204%20of%20the%208%20patients%20treated%20for%20M.%20simiae%20infection.%20Here%2C%20we%20describe%20a%20specific%20cluster%20corresponding%20to%20a%20large%20cohort%20of%20patients%20with%20M.%20simiae%2C%20a%20rare%20nontuberculous%20mycobacterium%20associated%20with%20low%20pathogenicity%20and%20poor%20susceptibility%20to%20antibiotics.%22%2C%22date%22%3A%222018%5C%2F07%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1128%5C%2FAAC.00395-18%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Faac.asm.org%5C%2Fcontent%5C%2F62%5C%2F7%5C%2Fe00395-18%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220066-4804%2C%201098-6596%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A39%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22GDEKIMV2%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22D%5Cu2019Ambrosio%20et%20al.%22%2C%22parsedDate%22%3A%222018-03-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BD%26%23x2019%3BAmbrosio%2C%20L.%2C%20Bothamley%2C%20G.%2C%20Caminero%20Luna%2C%20J.%20A.%2C%20Duarte%2C%20R.%2C%20Guglielmetti%2C%20L.%2C%20Mu%26%23xF1%3Boz%20Torrico%2C%20M.%2C%20Payen%2C%20M.%20C.%2C%20Saavedra%20Herrera%2C%20N.%2C%20Salazar%20Lezama%2C%20M.%20A.%2C%20Skrahina%2C%20A.%2C%20Tadolini%2C%20M.%2C%20Tiberi%2C%20S.%2C%20Veziris%2C%20N.%20and%20Migliori%2C%20G.%20B.%20%282018%29.%20%26lt%3Bb%26gt%3BTeam%20approach%20to%20manage%20difficult-to-treat%20TB%20cases%3A%20Experiences%20in%20Europe%20and%20beyond%26lt%3B%5C%2Fb%26gt%3B.%20Pulmonology%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%2C%20132%26%23x2013%3B141%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rppnen.2017.10.005%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rppnen.2017.10.005%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Team%20approach%20to%20manage%20difficult-to-treat%20TB%20cases%3A%20Experiences%20in%20Europe%20and%20beyond%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22D%5Cu2019Ambrosio%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20A.%22%2C%22lastName%22%3A%22Caminero%20Luna%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%22%2C%22lastName%22%3A%22Duarte%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Mu%5Cu00f1oz%20Torrico%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20C.%22%2C%22lastName%22%3A%22Payen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Saavedra%20Herrera%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%20A.%22%2C%22lastName%22%3A%22Salazar%20Lezama%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Skrahina%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Tadolini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20B.%22%2C%22lastName%22%3A%22Migliori%22%7D%5D%2C%22abstractNote%22%3A%22As%20recommended%20by%20the%20World%20Health%20Organization%20%28WHO%29%2C%20optimal%20management%20of%20MDR-TB%20cases%20can%20be%20ensured%20by%20a%20multi-speciality%20consultation%20body%20known%20as%20%5Cu2018TB%20Consilium%5Cu2019.%20This%20body%20usually%20includes%20different%20medical%20specialities%2C%20competences%20and%20perspectives%20%28e.g.%2C%20clinical%20expertise%20both%20for%20adults%20and%20children%3B%20surgical%2C%20radiological%20and%20public%20health%20expertise%3B%20psychological%20background%20and%20nursing%20experience%2C%20among%20others%29%2C%20thus%20lowering%20the%20risk%20of%20making%20mistakes%20%5Cu2013%20or%20managing%20the%20patients%20inappropriately%2C%20in%20order%20to%20improve%20their%20clinical%20outcomes.%20At%20present%2C%20several%20high%20MDR-TB%20burden%20countries%20in%20the%20different%20WHO%20regions%20%28and%20beyond%29%20have%20introduced%20TB%20Consilium-like%20bodies%20at%20the%20national%20or%20subnational%20level%20to%20reach%20consensus%20on%20the%20best%20treatment%20approach%20for%20their%20patients%20affected%20by%20TB.%20In%20addition%2C%20in%20countries%5C%2Fsettings%20where%20a%20formal%20system%20of%20consultation%20does%20not%20exist%2C%20specialized%20staff%20from%20MDR-TB%20reference%20centres%20or%20international%20organizations%20usually%20spend%20a%20considerable%20amount%20of%20their%20working%20time%20responding%20to%20phone%20or%20e-mail%20clinical%20queries%20on%20how%20to%20manage%20M%5C%2FXDR-TB%20cases.%20The%20aim%20of%20this%20manuscript%20is%20to%20describe%20the%20different%20experiences%20with%20the%20TB%20Consilia%20both%20at%20the%20international%20level%20%28European%20Respiratory%20Society%20%5Cu2013%20ERS%5C%2FWHO%20TB%20Consilium%29%20and%20in%20some%20of%20the%20countries%20where%20this%20experience%20operates%20successfully%20in%20Europe%20and%20beyond.%20The%20Consilium%20experiences%20are%20described%20around%20the%20following%20topics%3A%20%281%29%20history%2C%20aims%20and%20focus%3B%20%282%29%20management%20and%20funding%3B%20%283%29%20technical%20functioning%20and%20structure%3B%20%284%29%20results%20achieved.%20In%20addition%20a%20comparative%20analysis%20of%20the%20TB%20Consilia%20in%20the%20different%20countries%20has%20been%20performed.%22%2C%22date%22%3A%22March%201%2C%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rppnen.2017.10.005%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS217351151730163X%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222531-0437%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A42%3A52Z%22%7D%7D%2C%7B%22key%22%3A%223DDEFFQ5%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gras%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGras%2C%20J.%2C%20De%20Castro%2C%20N.%2C%20Montlahuc%2C%20C.%2C%20Champion%2C%20L.%2C%20Scemla%2C%20A.%2C%20Matignon%2C%20M.%2C%20Lach%26%23xE2%3Btre%2C%20M.%2C%20Raskine%2C%20L.%2C%20Grall%2C%20N.%2C%20Peraldi%2C%20M.%20N.%20and%20Molina%2C%20J.%20M.%20%282018%29.%20%26lt%3Bb%26gt%3BClinical%20characteristics%2C%20risk%20factors%2C%20and%20outcome%20of%20tuberculosis%20in%20kidney%20transplant%20recipients%3A%20A%20multicentric%20case-control%20study%20in%20a%20low-endemic%20area%26lt%3B%5C%2Fb%26gt%3B.%20Transplant%20Infectious%20Disease%20%26lt%3Bi%26gt%3B20%26lt%3B%5C%2Fi%26gt%3B%2C%20e12943%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Ftid.12943%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Ftid.12943%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Clinical%20characteristics%2C%20risk%20factors%2C%20and%20outcome%20of%20tuberculosis%20in%20kidney%20transplant%20recipients%3A%20A%20multicentric%20case-control%20study%20in%20a%20low-endemic%20area%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julien%22%2C%22lastName%22%3A%22Gras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22De%20Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Montlahuc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laure%22%2C%22lastName%22%3A%22Champion%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%22%2C%22lastName%22%3A%22Scemla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Matignon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Lach%5Cu00e2tre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laurent%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Grall%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%20No%5Cu00eblle%22%2C%22lastName%22%3A%22Peraldi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Michel%22%2C%22lastName%22%3A%22Molina%22%7D%5D%2C%22abstractNote%22%3A%22Objectives%20Tuberculosis%20%28TB%29%20is%20a%20rare%20but%20life-threatening%20infection%20after%20solid%20organ%20transplant.%20The%20present%20study%20was%20undertaken%20to%20assess%20the%20clinical%20features%2C%20risk%20factors%2C%20and%20outcome%20of%20TB%20after%20kidney%20transplantation%20in%20a%20low-prevalence%20area.%20Methods%20We%20conducted%20a%20retrospective%20study%2C%20describing%20all%20kidney%20transplant%20recipients%20diagnosed%20with%20TB%20between%202005%20and%202015%20in%203%20French%20centers.%20For%20each%20TB%20case%2C%202%20controls%20without%20TB%20were%20identified%20and%20matched%20by%20center%2C%20age%2C%20transplant%20date%2C%20and%20birth%20country.%20Risk%20factors%20associated%20with%20TB%20were%20identified%20and%20survival%20estimated.%20Results%20Thirty-two%20cases%20and%2064%20control%20patients%20were%20included%20among%203974%20transplantations.%20The%20prevalence%20of%20TB%20was%200.83%25.%20Median%20age%20at%20the%20time%20of%20diagnosis%20was%2064%20years%3B%2075%25%20were%20born%20in%20a%20high%20TB%20prevalence%20country%2C%20but%20only%203%20had%20received%20isoniazid%20prophylaxis%20for%20latent%20TB%20infection.%20TB%20occurred%20at%20a%20median%20of%2022%20months%20after%20transplantation.%20On%20diagnosis%2C%2066%25%20had%20disseminated%20infection.%20Median%20duration%20of%20treatment%20was%209%20months.%20Immunosuppressive%20therapy%20changes%20were%20necessary%20in%20all%20patients%20because%20of%20drug-drug%20interactions.%20Among%20cases%2C%205%20deaths%20occurred%20during%20follow-up%20%28median%20duration%3A%2041%20months%29%2C%20one%20directly%20related%20with%20TB.%20Survival%20was%20significantly%20lower%20in%20transplant%20recipients%20with%20TB%2C%20as%20compared%20to%20controls%20%28P%20%3D%20.001%29.%20No%20predictive%20factors%20of%20tuberculosis%20after%20transplantation%20were%20statistically%20significant%20in%20univariate%20analysis.%20Conclusion%20TB%20in%20kidney%20transplant%20recipients%20is%20a%20rare%20and%20late%20event%2C%20but%20is%20associated%20with%20significantly%20reduced%20survival.%20Our%20results%20emphasize%20the%20need%20for%20systematic%20screening%20for%20LTBI%2C%20followed%20by%20IPT%20in%20high-risk%20patients.%22%2C%22date%22%3A%222018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1111%5C%2Ftid.12943%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Ftid.12943%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221399-3062%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T08%3A29%3A44Z%22%7D%7D%2C%7B%22key%22%3A%22GJQMGE59%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Griffith%20et%20al.%22%2C%22parsedDate%22%3A%222018-12-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGriffith%2C%20D.%20E.%2C%20Eagle%2C%20G.%2C%20Thomson%2C%20R.%2C%20Aksamit%2C%20T.%20R.%2C%20Hasegawa%2C%20N.%2C%20Morimoto%2C%20K.%2C%20Addrizzo-Harris%2C%20D.%20J.%2C%20O%26%23x2019%3BDonnell%2C%20A.%20E.%2C%20Marras%2C%20T.%20K.%2C%20Flume%2C%20P.%20A.%2C%20Loebinger%2C%20M.%20R.%2C%20Morgan%2C%20L.%2C%20Codecasa%2C%20L.%20R.%2C%20Hill%2C%20A.%20T.%2C%20Ruoss%2C%20S.%20J.%2C%20Yim%2C%20J.-J.%2C%20Ringshausen%2C%20F.%20C.%2C%20Field%2C%20S.%20K.%2C%20Philley%2C%20J.%20V.%2C%20Wallace%2C%20R.%20J.%2C%20van%20Ingen%2C%20J.%2C%20Coulter%2C%20C.%2C%20Nezamis%2C%20J.%20and%20Winthrop%2C%20K.%20L.%20%282018%29.%20%26lt%3Bb%26gt%3BAmikacin%20Liposome%20Inhalation%20Suspension%20for%20Treatment-Refractory%20Lung%20Disease%20Caused%20by%20Mycobacterium%20avium%20Complex%20%28CONVERT%29.%20A%20Prospective%2C%20Open-Label%2C%20Randomized%20Study%26lt%3B%5C%2Fb%26gt%3B.%20Am%20J%20Respir%20Crit%20Care%20Med%20%26lt%3Bi%26gt%3B198%26lt%3B%5C%2Fi%26gt%3B%2C%201559%26%23x2013%3B1569%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1164%5C%2Frccm.201807-1318OC%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1164%5C%2Frccm.201807-1318OC%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Amikacin%20Liposome%20Inhalation%20Suspension%20for%20Treatment-Refractory%20Lung%20Disease%20Caused%20by%20Mycobacterium%20avium%20Complex%20%28CONVERT%29.%20A%20Prospective%2C%20Open-Label%2C%20Randomized%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Griffith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gina%22%2C%22lastName%22%3A%22Eagle%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Thomson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20R.%22%2C%22lastName%22%3A%22Aksamit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Naoki%22%2C%22lastName%22%3A%22Hasegawa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kozo%22%2C%22lastName%22%3A%22Morimoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Doreen%20J.%22%2C%22lastName%22%3A%22Addrizzo-Harris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20E.%22%2C%22lastName%22%3A%22O%5Cu2019Donnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodore%20K.%22%2C%22lastName%22%3A%22Marras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%20A.%22%2C%22lastName%22%3A%22Flume%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R.%22%2C%22lastName%22%3A%22Loebinger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucy%22%2C%22lastName%22%3A%22Morgan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Luigi%20R.%22%2C%22lastName%22%3A%22Codecasa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adam%20T.%22%2C%22lastName%22%3A%22Hill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20J.%22%2C%22lastName%22%3A%22Ruoss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae-Joon%22%2C%22lastName%22%3A%22Yim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Felix%20C.%22%2C%22lastName%22%3A%22Ringshausen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephen%20K.%22%2C%22lastName%22%3A%22Field%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Julie%20V.%22%2C%22lastName%22%3A%22Philley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Wallace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakko%22%2C%22lastName%22%3A%22van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chris%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%22%2C%22lastName%22%3A%22Nezamis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20L.%22%2C%22lastName%22%3A%22Winthrop%22%7D%5D%2C%22abstractNote%22%3A%22Rationale%3A%20Improved%20therapeutic%20options%20are%20needed%20for%20patients%20with%20treatment-refractory%20nontuberculous%20mycobacterial%20lung%20disease%20caused%20by%20Mycobacterium%20avium%20complex%20%28MAC%29.%5Cn%5CnObjectives%3A%20To%20evaluate%20the%20efficacy%20and%20safety%20of%20daily%20amikacin%20liposome%20inhalation%20suspension%20%28ALIS%29%20added%20to%20standard%20guideline-based%20therapy%20%28GBT%29%20in%20patients%20with%20refractory%20MAC%20lung%20disease.%5Cn%5CnMethods%3A%20Adults%20with%20amikacin-susceptible%20MAC%20lung%20disease%20and%20MAC-positive%20sputum%20cultures%20despite%20at%20least%206%20months%20of%20stable%20GBT%20were%20randomly%20assigned%20%282%3A1%29%20to%20receive%20ALIS%20with%20GBT%20%28ALIS%5Cu2009%2B%5Cu2009GBT%29%20or%20GBT%20alone.%20Once-daily%20ALIS%20was%20supplied%20in%20single-use%20vials%20delivering%20590%20mg%20amikacin%20to%20the%20nebulizer.%20The%20primary%20endpoint%20was%20culture%20conversion%2C%20defined%20as%20three%20consecutive%20monthly%20MAC-negative%20sputum%20cultures%20by%20Month%206.%5Cn%5CnMeasurements%20and%20Main%20Results%3A%20Enrolled%20patients%20%28ALIS%5Cu2009%2B%5Cu2009GBT%2C%20n%5Cu2009%3D%5Cu2009224%3B%20GBT-alone%2C%20n%5Cu2009%3D%5Cu2009112%29%20were%20a%20mean%2064.7%20years%20old%20and%2069.3%25%20female.%20Most%20had%20underlying%20bronchiectasis%20%2862.5%25%29%2C%20chronic%20obstructive%20pulmonary%20disease%20%2814.3%25%29%2C%20or%20both%20%2811.9%25%29.%20Culture%20conversion%20was%20achieved%20by%2065%20of%20224%20patients%20%2829.0%25%29%20with%20ALIS%5Cu2009%2B%5Cu2009GBT%20and%2010%20of%20112%20%288.9%25%29%20with%20GBT%20alone%20%28odds%20ratio%2C%204.22%3B%2095%25%20confidence%20interval%2C%202.08%5Cu20138.57%3B%20P%5Cu2009%26lt%3B%5Cu20090.001%29.%20Patients%20in%20the%20ALIS%5Cu2009%2B%5Cu2009GBT%20arm%20versus%20GBT%20alone%20were%20more%20likely%20to%20achieve%20conversion%20%28hazard%20ratio%2C%203.90%3B%2095%25%20confidence%20interval%2C%202.00%5Cu20137.60%29.%20Respiratory%20adverse%20events%20%28primarily%20dysphonia%2C%20cough%2C%20and%20dyspnea%29%20were%20reported%20in%2087.4%25%20of%20patients%20receiving%20ALIS%5Cu2009%2B%5Cu2009GBT%20and%2050.0%25%20receiving%20GBT%20alone%3B%20serious%20treatment-emergent%20adverse%20events%20occurred%20in%2020.2%25%20and%2017.9%25%20of%20patients%2C%20respectively.%5Cn%5CnConclusions%3A%20Addition%20of%20ALIS%20to%20GBT%20for%20treatment-refractory%20MAC%20lung%20disease%20achieved%20significantly%20greater%20culture%20conversion%20by%20Month%206%20than%20GBT%20alone%2C%20with%20comparable%20rates%20of%20serious%20adverse%20events.%5Cn%5CnClinical%20trial%20registered%20with%20www.clinicaltrials.gov%20%28NCT02344004%29.%22%2C%22date%22%3A%222018-12-15%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1164%5C%2Frccm.201807-1318OC%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.atsjournals.org%5C%2Fdoi%5C%2F10.1164%5C%2Frccm.201807-1318OC%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221073-449X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-04-19T20%3A42%3A05Z%22%7D%7D%2C%7B%22key%22%3A%226ECFMX46%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222018-03-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Barkane%2C%20L.%2C%20D%26%23xFB%3B%2C%20D.%20L.%2C%20Marigot-Outtandy%2C%20D.%2C%20Robert%2C%20J.%2C%20Veziris%2C%20N.%2C%20Yazdanpanah%2C%20Y.%2C%20Kuksa%2C%20L.%2C%20Caumes%2C%20E.%20and%20Fr%26%23xE9%3Bchet-Jachym%2C%20M.%20%282018%29.%20%26lt%3Bb%26gt%3BSafety%20and%20efficacy%20of%20exposure%20to%20bedaquiline%26%23x2212%3Bdelamanid%20in%20multidrug-resistant%20tuberculosis%3A%20a%20case%20series%20from%20France%20and%20Latvia%26lt%3B%5C%2Fb%26gt%3B.%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%2C%201702550%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.02550-2017%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.02550-2017%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Safety%20and%20efficacy%20of%20exposure%20to%20bedaquiline%5Cu2212delamanid%20in%20multidrug-resistant%20tuberculosis%3A%20a%20case%20series%20from%20France%20and%20Latvia%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Barkane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Damien%20Le%22%2C%22lastName%22%3A%22D%5Cu00fb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhiba%22%2C%22lastName%22%3A%22Marigot-Outtandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yazdan%22%2C%22lastName%22%3A%22Yazdanpanah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liga%22%2C%22lastName%22%3A%22Kuksa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Caumes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mathilde%22%2C%22lastName%22%3A%22Fr%5Cu00e9chet-Jachym%22%7D%5D%2C%22abstractNote%22%3A%22Extract%5CnMultidrug-resistant%20%28MDR%29%20and%20extensively%20drug-resistant%20%28XDR%29%20tuberculosis%20%28TB%29%20represent%20a%20therapeutic%20challenge%20%5B1%5D.%20Two%20anti-TB%20agents%2C%20bedaquiline%20and%20delamanid%2C%20have%20been%20recently%20approved%20for%20the%20treatment%20of%20MDR%5C%2FXDR-TB.%20Bedaquiline%20has%20a%20terminal%20half-life%20of%205.5%20months%2C%20in%20contrast%20with%20the%20short%20half-life%20of%20delamanid%20%2838%20h%29.%20Both%20drugs%20increase%20the%20QTcF%20%28Fridericia-corrected%20QT%29%20interval%2C%20although%20no%20clinically%20significant%20cardiac%20events%20have%20been%20reported%20in%20patients%20treated%20with%20one%20of%20these%20drugs%20%5B2%2C%203%5D.%20The%20clinical%20trials%20that%20led%20to%20approval%20of%20bedaquiline%20and%20delamanid%20tested%20these%20drugs%20by%20adding%20one%20of%20them%2C%20for%20a%20duration%20of%2024%20weeks%20and%206%5Cu20138%20months%2C%20respectively%2C%20to%20optimised%20background%20%5B2%2C%203%5D.%20To%20date%2C%20only%20six%20cases%20treated%20with%20the%20bedaquiline%5Cu2212delamanid%20combination%20have%20been%20reported%2C%20mostly%20presenting%20interim%20results%20%5B4%5Cu20136%5D.%20The%20World%20Health%20Organization%20%28WHO%29%20recommends%20to%20use%20these%20drugs%20for%20a%20standardised%20duration%20of%2024%20weeks%2C%20the%20concomitant%20use%20of%20bedaquiline%20and%20delamanid%20being%20restricted%20to%20patients%20with%20%5Cu201cno%20other%20therapeutic%20options%5Cu201d.%20Otherwise%2C%20it%20is%20recommended%20to%20start%20the%20two%20drugs%20sequentially%20after%20a%20washout%20period%20of%206%20months%2C%20when%20switching%20from%20bedaquiline%20to%20delamanid%2C%20and%205%20days%2C%20when%20switching%20from%20delamanid%20to%20bedaquiline%20%5B7%5D.%20We%20report%20the%20results%20of%20exposure%20to%20concomitant%20and%20sequential%20treatment%20with%20bedaquiline%20and%20delamanid%2C%20including%20treatment%20courses%20beyond%2024%20weeks%2C%20as%20part%20of%20multidrug%20MDR%5C%2FXDR-TB%20regimens.%5CnTweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetGood%20tolerability%20of%20exposure%20to%20bedaquiline%5Cu2212delamanid%20association%20in%20MDR%5C%2FXDR-TB%20patients%20http%3A%5C%2F%5C%2Fow.ly%5C%2F4uvr30i7az4%22%2C%22date%22%3A%222018%5C%2F03%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.02550-2017%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F51%5C%2F3%5C%2F1702550%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T16%3A28%3A08Z%22%7D%7D%2C%7B%22key%22%3A%22AH5RNSA8%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222018-08-01%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Tiberi%2C%20S.%2C%20Burman%2C%20M.%2C%20Kunst%2C%20H.%2C%20Wejse%2C%20C.%2C%20Togonidze%2C%20T.%2C%20Bothamley%2C%20G.%20and%20Lange%2C%20C.%20%282018%29.%20%26lt%3Bb%26gt%3BQT%20prolongation%20and%20cardiac%20toxicity%20of%20new%20tuberculosis%20drugs%20in%20Europe%3A%20a%20Tuberculosis%20Network%20European%20Trialsgroup%20%28TBnet%29%20study%26lt%3B%5C%2Fb%26gt%3B.%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B52%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00537-2018%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00537-2018%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22QT%20prolongation%20and%20cardiac%20toxicity%20of%20new%20tuberculosis%20drugs%20in%20Europe%3A%20a%20Tuberculosis%20Network%20European%20Trialsgroup%20%28TBnet%29%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Simon%22%2C%22lastName%22%3A%22Tiberi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Burman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Heinke%22%2C%22lastName%22%3A%22Kunst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Wejse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tamar%22%2C%22lastName%22%3A%22Togonidze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Graham%22%2C%22lastName%22%3A%22Bothamley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%5D%2C%22abstractNote%22%3A%22Tweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetFew%20cardiac%20arrhythmias%20and%20no%20fatalities%20were%20observed%20in%20MDR-TB%20patients%20treated%20with%20bedaquiline%20and%20delamanid%20http%3A%5C%2F%5C%2Fow.ly%5C%2F2tC030koXJa%22%2C%22date%22%3A%222018%5C%2F08%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00537-2018%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F52%5C%2F2%5C%2F1800537%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T08%3A35%3A42Z%22%7D%7D%2C%7B%22key%22%3A%2263JMDE9T%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Guglielmetti%20et%20al.%22%2C%22parsedDate%22%3A%222018-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGuglielmetti%2C%20L.%2C%20Veziris%2C%20N.%2C%20Aubry%2C%20A.%2C%20Brossier%2C%20F.%2C%20Bernard%2C%20C.%2C%20Sougakoff%2C%20W.%2C%20Jarlier%2C%20V.%2C%20Robert%2C%20J.%20and%20surveillance%2C%20%20for%20the%20L.%20N.%20for%20M.%20%282018%29.%20%26lt%3Bi%26gt%3BRisk%20factors%20for%20extensive%20drug%20resistance%20in%20multidrug-resistant%20tuberculosis%20cases%3A%20a%20case-case%20study%26lt%3B%5C%2Fi%26gt%3B.%2C%20doi%3Ainfo%3Adoi%5C%2F10.5588%5C%2Fijtld.17.0387.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Risk%20factors%20for%20extensive%20drug%20resistance%20in%20multidrug-resistant%20tuberculosis%20cases%3A%20a%20case-case%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22C.%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22for%20the%20Laboratory%20Network%20for%20MDR%22%2C%22lastName%22%3A%22surveillance%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%221%20January%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ingentaconnect.com%5C%2Fcontent%5C%2Fiuatld%5C%2Fijtld%5C%2F2018%5C%2F00000022%5C%2F00000001%5C%2Fart00013%253bjsessionid%3D5dlko4neq1ob6.x-ic-live-02%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T16%3A42%3A01Z%22%7D%7D%2C%7B%22key%22%3A%22STCIKMUY%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kouriba%20et%20al.%22%2C%22parsedDate%22%3A%222018-06-20%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKouriba%2C%20B.%2C%20Ouwe%20Missi%20Oukem-Boyer%2C%20O.%2C%20Traor%26%23xE9%3B%2C%20B.%2C%20Tour%26%23xE9%3B%2C%20A.%2C%20Raskine%2C%20L.%20and%20Babin%2C%20F.%20X.%20%282018%29.%20%26lt%3Bb%26gt%3BInstalling%20biosafety%20level%203%20containment%20laboratories%20in%20low-%20and%20middle-income%20countries%3A%20challenges%20and%20prospects%20from%20Mali%26%23x2019%3Bs%20experience%26lt%3B%5C%2Fb%26gt%3B.%20New%20Microbes%20New%20Infect%20%26lt%3Bi%26gt%3B26%26lt%3B%5C%2Fi%26gt%3B%2C%20S74%26%23x2013%3BS77%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.nmni.2018.05.011%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.nmni.2018.05.011%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Installing%20biosafety%20level%203%20containment%20laboratories%20in%20low-%20and%20middle-income%20countries%3A%20challenges%20and%20prospects%20from%20Mali%27s%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Kouriba%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Ouwe%20Missi%20Oukem-Boyer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22B.%22%2C%22lastName%22%3A%22Traor%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Tour%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.X.%22%2C%22lastName%22%3A%22Babin%22%7D%5D%2C%22abstractNote%22%3A%22In%20Mali%2C%20the%20incidence%20of%20tuberculosis%20%28TB%29%20is%20estimated%20at%2056%20cases%20per%20100%20000%20people%2C%20with%20a%20prevalence%20of%20multidrug-resistant%20TB%20in%20new%20cases%20of%201.7%25%20%28range%2C%200.3%5Cu20133.1%25%29%20and%20in%20retreatment%20cases%20of%2017%25%20%28range%2C%204.4%5Cu201330%25%29.%20Appropriate%20biosafety%20conditions%20for%20performing%20routine%20TB%20culture%20and%20antimicrobial%20susceptibility%20testing%20have%20been%20lacking.%20In%202015%2C%20a%20biosafety%20level%203%20%28BSL3%29%20laboratory%20set%20up%20in%20a%20shipping%20container%20was%20donated%20to%20the%20Malian%20Ministry%20of%20Health%20and%20Public%20Hygiene%20to%20provide%20capacity%20for%20TB%20testing.%20This%20laboratory%20is%20now%20managed%20by%20Malian%20laboratory%20staff%20and%20is%20processing%20samples%20at%20the%20national%20level.%20We%20explain%20the%20necessary%20steps%20for%20establishing%20and%20running%20a%20BSL3%20laboratory.%20Despite%20the%20acute%20need%20for%20functioning%20and%20sustainable%20BSL3%20laboratories%2C%20low-%20and%20middle-income%20countries%20are%20faced%20with%20a%20complex%20process%20and%20must%20overcome%20many%20challenges.%22%2C%22date%22%3A%222018-6-20%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.nmni.2018.05.011%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.ncbi.nlm.nih.gov%5C%2Fpmc%5C%2Farticles%5C%2FPMC6205564%5C%2F%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222052-2975%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-12T08%3A29%3A50Z%22%7D%7D%2C%7B%22key%22%3A%226YZ9YSRS%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Lecorche%20et%20al.%22%2C%22parsedDate%22%3A%222018-04-01%22%2C%22numChildren%22%3A4%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLecorche%2C%20E.%2C%20Haenn%2C%20S.%2C%20Mougari%2C%20F.%2C%20Kumanski%2C%20S.%2C%20Veziris%2C%20N.%2C%20Benmansour%2C%20H.%2C%20Raskine%2C%20L.%2C%20Moulin%2C%20L.%2C%20Cambau%2C%20E.%2C%20Aubry%2C%20A.%2C%20Brossier%2C%20F.%2C%20Chauffour%2C%20A.%2C%20Jaffre%2C%20J.%2C%20Jarlier%2C%20V.%2C%20Robert%2C%20J.%20and%20Sougakoff%2C%20W.%20%282018%29.%20%26lt%3Bb%26gt%3BComparison%20of%20methods%20available%20for%20identification%20of%20Mycobacterium%20chimaera%26lt%3B%5C%2Fb%26gt%3B.%20Clinical%20Microbiology%20and%20Infection%20%26lt%3Bi%26gt%3B24%26lt%3B%5C%2Fi%26gt%3B%2C%20409%26%23x2013%3B413%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2017.07.031%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cmi.2017.07.031%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20methods%20available%20for%20identification%20of%20Mycobacterium%20chimaera%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Lecorche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Haenn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S.%22%2C%22lastName%22%3A%22Kumanski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H.%22%2C%22lastName%22%3A%22Benmansour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Raskine%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%22%2C%22lastName%22%3A%22Moulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Aubry%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Jaffre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22V.%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22%26lt%3Bh2%26gt%3BAbstract%26lt%3B%5C%2Fh2%26gt%3B%26lt%3Bh3%26gt%3BObjectives%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3B%26lt%3Bi%26gt%3BMycobacterium%20chimaera%26lt%3B%5C%2Fi%26gt%3B%20is%20a%20recently%20described%20nontuberculous%20mycobacterium%20belonging%20to%20the%20%26lt%3Bi%26gt%3BMycobacterium%20avium%26lt%3B%5C%2Fi%26gt%3B%20complex%20%28MAC%29.%20Because%20this%20species%20is%20implicated%20in%20a%20worldwide%20outbreak%20due%20to%20contaminated%20heater%5Cu2013cooler%20unit%20water%20tanks%20during%20open-heart%20surgery%2C%20it%20has%20become%20mandatory%20for%20clinical%20microbiology%20laboratories%20to%20be%20able%20to%20differentiate%20%26lt%3Bi%26gt%3BM.%20chimaera%26lt%3B%5C%2Fi%26gt%3B%20from%20the%20other%20MAC%20species%2C%20especially%20%26lt%3Bi%26gt%3BM.%20intracellulare%26lt%3B%5C%2Fi%26gt%3B.%20Such%20identification%20has%20so%20far%20been%20restricted%20to%20specialized%20laboratories%20because%20it%20required%20the%20analysis%20of%20several%20gene%20sequences.%20The%20aim%20of%20this%20study%20was%20to%20evaluate%20commercial%20methods%20for%20identifying%20%26lt%3Bi%26gt%3BM.%20chimaera%26lt%3B%5C%2Fi%26gt%3B%20with%20regard%20to%20the%20reference%20gene%20sequencing%20ITS%2C%20the%20internal%20transcribed%20spacer%2016%5Cu201323S.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BMethods%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BForty-seven%20clinical%20and%20environmental%20isolates%20including%2041%20MAC%20were%20identified%20by%20%28a%29%20PCR%20sequencing%20of%20the%20ITS%20and%20%26lt%3Bi%26gt%3Bhsp65%26lt%3B%5C%2Fi%26gt%3B%20genes%2C%20%28b%29%20three%20molecular%20biology%20kits%20%28INNO-LiPA%20Mycobacteria%2C%20GenoType%20Mycobacterium%20CM%20and%20GenoType%20NTM-DR%29%20and%20%28c%29%20matrix-assisted%20desorption%20ionization%5Cu2013time%20of%20flight%20mass%20spectrometry%20%28MALDI-TOF%20MS%29%20using%20Microflex%20LT.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BResults%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BThere%20was%20a%20high%20concordance%20for%20species%20determination%20between%20the%20reference%20ITS%20sequencing%20and%20the%20GenoType%20NTM-DR%20test%20%2839%5C%2F41%2C%2095%25%29%2C%20the%20INNO-LiPA%20Mycobacteria%20test%20%2838%5C%2F41%2C%2093%25%29%20and%20the%20%26lt%3Bi%26gt%3Bhsp65%26lt%3B%5C%2Fi%26gt%3B%20sequencing%20%2838%5C%2F41%2C%2093%25%29.%20The%20GenoType%20Mycobacterium%20CM%20test%20did%20not%20distinguish%20%26lt%3Bi%26gt%3BM.%20chimaera%26lt%3B%5C%2Fi%26gt%3B%20from%20%26lt%3Bi%26gt%3BM.%20intracellulare%26lt%3B%5C%2Fi%26gt%3B.%20MALDI-TOF%20MS%20distinguished%20two%20%26lt%3Bi%26gt%3BM.%20chimaera%26lt%3B%5C%2Fi%26gt%3B%5Cu2013%26lt%3Bi%26gt%3BM.%20intracellulare%26lt%3B%5C%2Fi%26gt%3B%20groups%20separated%20from%20%26lt%3Bi%26gt%3BM.%20avium%26lt%3B%5C%2Fi%26gt%3B%20and%20from%20the%20other%20mycobacterial%20species%20on%20a%20score-oriented%20dendrogram%2C%20but%20it%20also%20failed%20to%20differentiate%20the%20two%20species.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BConclusions%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BINNO-LiPA%20Mycobacteria%20and%20GenoType%20NTM-DR%20are%20efficient%20assays%20for%20%26lt%3Bi%26gt%3BM.%20chimaera%26lt%3B%5C%2Fi%26gt%3B%20identification%20in%20clinical%20microbiology%20laboratories.%26lt%3B%5C%2Fp%26gt%3B%22%2C%22date%22%3A%222018%5C%2F04%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cmi.2017.07.031%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.clinicalmicrobiologyandinfection.com%5C%2Farticle%5C%2FS1198-743X%2817%2930417-2%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221198-743X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-05T15%3A09%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22KIQLFFY4%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Levi%20et%20al.%22%2C%22parsedDate%22%3A%222018-12-21%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BLevi%2C%20L.%20I.%2C%20Schlemmer%2C%20F.%2C%20de%20Castro%2C%20N.%2C%20Brun%2C%20O.%2C%20Veziris%2C%20N.%2C%20Argemi%2C%20X.%2C%20Roupret%2C%20M.%2C%20Launay%2C%20O.%2C%20Bergeron%2C%20A.%20and%20Groh%2C%20M.%20%282018%29.%20%26lt%3Bb%26gt%3BBacillus%20Calmette-Guerin%20infection%20following%20intravesical%20instillation%3A%20Does%20the%20strain%20matter%3F%26lt%3B%5C%2Fb%26gt%3B%20M%26%23xE9%3Bdecine%20et%20Maladies%20Infectieuses%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2018.11.014%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.medmal.2018.11.014%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Bacillus%20Calmette-Guerin%20infection%20following%20intravesical%20instillation%3A%20Does%20the%20strain%20matter%3F%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22L.%20I.%22%2C%22lastName%22%3A%22Levi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22F.%22%2C%22lastName%22%3A%22Schlemmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22de%20Castro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Brun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22X.%22%2C%22lastName%22%3A%22Argemi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Roupret%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22O.%22%2C%22lastName%22%3A%22Launay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22A.%22%2C%22lastName%22%3A%22Bergeron%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22M.%22%2C%22lastName%22%3A%22Groh%22%7D%5D%2C%22abstractNote%22%3A%22Purpose%5CnIntravesical%20BCG%20is%20the%20standard%20treatment%20of%20non-muscle%20invasive%20bladder%20cancer.%20No%20difference%20has%20yet%20been%20reported%20in%20the%20safety%20profiles%20of%20the%20various%20BCG%20strains.%5CnMethods%5CnA%20nationwide%20multidisciplinary%20retrospective%20survey%20was%20conducted%20between%20January%202013%20and%20December%202016%20to%20identify%20cases%20of%20BCG%20infection%20and%20differentiate%20them%20based%20on%20the%20type%20of%20BCG%20strain%20used.%5CnResults%5CnForty%20patients%20were%20identified%20%28BCG%20RIVM%2028%3B%20other%20strains%208%3B%20unknown%204%29.%20Patients%20treated%20with%20BCG%20RIVM%20were%20less%20severely%20ill%2C%20with%20fewer%20occurrences%20of%20septic%20shock%20%283.6%25%20vs.%2050%25%2C%20P%3D0.003%29%20and%20ICU%20admission%20%287.1%25%20vs.%2062.5%25%2C%20P%3D0.003%29.%20A%20higher%20frequency%20of%20pulmonary%20miliaries%20%2871.4%25%20vs.%2012.5%25%2C%20P%3D0.005%29%20but%20lower%20transaminase%20levels%20%28mean%20AST%2065%20vs.%20264%20U%5C%2FL%2C%20P%3D0.001%29%20were%20observed%20in%20these%20patients.%20No%20difference%20in%20terms%20of%20recovery%20was%20reported.%5CnConclusion%5CnThe%20type%20of%20BCG%20strain%20could%20correlate%20with%20the%20frequency%20and%20severity%20of%20subsequent%20BCG%20infections.%5CnR%5Cu00e9sum%5Cu00e9%5CnObjectifs%5CnLa%20BCG-th%5Cu00e9rapie%20est%20le%20traitement%20standard%20des%20tumeurs%20de%20vessie%20n%5Cu2019infiltrant%20pas%20la%20musculeuse.%20Aucune%20diff%5Cu00e9rence%20de%20tol%5Cu00e9rance%20entre%20les%20diff%5Cu00e9rentes%20souches%20de%20BCG%20n%5Cu2019a%20%5Cu00e9t%5Cu00e9%20rapport%5Cu00e9e.%5CnPatients%20et%20m%5Cu00e9thodes%5CnUne%20%5Cu00e9tude%20multidisciplinaire%20r%5Cu00e9trospective%20fran%5Cu00e7aise%20a%20%5Cu00e9t%5Cu00e9%20men%5Cu00e9e%20entre%20janvier%202013%20et%20d%5Cu00e9cembre%202016%20pour%20identifier%20les%20cas%20de%20BCGites%20et%20comparer%20leur%20pr%5Cu00e9sentation%20clinique%20selon%20la%20souche%20utilis%5Cu00e9e.%5CnR%5Cu00e9sultats%5CnQuarante%20patients%20ont%20%5Cu00e9t%5Cu00e9%20inclus%5Cu00a0%3A%20%28BCG%20RIVM%2028%5Cu00a0%3B%20autres%20souches%208%5Cu00a0%3B%20inconnue%204%29.%20Les%20patients%20trait%5Cu00e9s%20avec%20BCG%20RIVM%20pr%5Cu00e9sentaient%20plus%20de%20miliaires%20pulmonaires%20%2871%2C4%5Cu00a0%25%20vs%2012%2C5%5Cu00a0%25%2C%20p%3D0%2C005%29%2C%20moins%20de%20chocs%20septiques%20%283%2C6%5Cu00a0%25%20vs%2050%5Cu00a0%25%2C%20p%3D0%2C003%29%2C%20des%20taux%20de%20transaminases%20plus%20bas%20%28moyenne%20AST%2065%20vs%20264%20U%5C%2FL%2C%20p%3D0%2C001%29%20et%20avaient%20moins%20recours%20%5Cu00e0%20la%20r%5Cu00e9animation%20%287%2C1%5Cu00a0%25%20vs%2062%2C5%5Cu00a0%25%2C%20p%3D0%2C003%29.%20L%5Cu2019%5Cu00e9volution%20%5Cu00e9tait%20superposable%20entre%20les%20deux%20groupes.%5CnConclusion%5CnLa%20souche%20de%20BCG%20pourrait%20influencer%20la%20fr%5Cu00e9quence%20et%20la%20s%5Cu00e9v%5Cu00e9rit%5Cu00e9%20d%5Cu2019une%20BCGite.%22%2C%22date%22%3A%22December%2021%2C%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.medmal.2018.11.014%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0399077X17310259%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220399-077X%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A35%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22Q4ZJ4XZI%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Machado%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMachado%2C%20D.%2C%20Lecorche%2C%20E.%2C%20Mougari%2C%20F.%2C%20Cambau%2C%20E.%20and%20Viveiros%2C%20M.%20%282018%29.%20%26lt%3Bb%26gt%3BInsights%20on%20Mycobacterium%20leprae%20Efflux%20Pumps%20and%20Their%20Implications%20in%20Drug%20Resistance%20and%20Virulence%26lt%3B%5C%2Fb%26gt%3B.%20Front%20Microbiol%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffmicb.2018.03072%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3389%5C%2Ffmicb.2018.03072%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Insights%20on%20Mycobacterium%20leprae%20Efflux%20Pumps%20and%20Their%20Implications%20in%20Drug%20Resistance%20and%20Virulence%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Machado%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuel%22%2C%22lastName%22%3A%22Lecorche%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Faiza%22%2C%22lastName%22%3A%22Mougari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Viveiros%22%7D%5D%2C%22abstractNote%22%3A%22Drug%20resistance%20in%20Mycobacterium%20leprae%20is%20assumed%20to%20be%20due%20to%20genetic%20alterations%20in%20the%20drug%20targets%20and%20reduced%20cell%20wall%20permeability.%20However%2C%20as%20observed%20in%20Mycobacterium%20tuberculosis%2C%20drug%20resistance%20may%20also%20result%20from%20the%20overactivity%20of%20efflux%20systems%2C%20which%20is%20mostly%20unexplored.%20In%20this%20perspective%2C%20we%20discuss%20known%20efflux%20pumps%20involved%20in%20M.%20tuberculosis%20drug%20resistance%20and%20virulence%20and%20investigate%20similar%20regions%20in%20the%20genome%20of%20M.%20leprae.%20In%20silico%20analysis%20reveals%20that%20the%20major%20M.%20tuberculosis%20efflux%20pumps%20known%20to%20be%20associated%20with%20drug%20resistance%20and%20virulence%20have%20been%20retained%20during%20the%20reductive%20evolutionary%20process%20that%20M.%20leprae%20underwent%2C%20e.g.%2C%20RND%20superfamily%2C%20the%20ABC%20transporter%20BacA%2C%20and%20the%20MFS%20P55.%20However%2C%20some%20are%20absent%20%28DinF%2C%20MATE%29%20while%20others%20are%20derepressed%20%28Mmr%2C%20SMR%29%20in%20M.%20leprae%20reflecting%20the%20specific%20environment%20where%20M.%20leprae%20may%20live.%20The%20occurrence%20of%20several%20multidrug%20resistance%20efflux%20transporters%20shared%20between%20M.%20leprae%20and%20M.%20tuberculosis%20reveals%20potential%20implications%20in%20drug%20resistance%20and%20virulence.%20The%20conservation%20of%20the%20described%20efflux%20systems%20in%20M.%20leprae%20upon%20genome%20reduction%20indicates%20that%20these%20systems%20are%20potentially%20required%20for%20its%20intracellular%20survival%20and%20lifestyle.%20They%20potentially%20are%20involved%20in%20M.%20leprae%20drug%20resistance%2C%20which%20could%20hamper%20leprosy%20treatment%20success.%20Studying%20M.%20leprae%20efflux%20pumps%20as%20new%20drug%20targets%20is%20useful%20for%20future%20leprosy%20therapeutics%2C%20enhancing%20the%20global%20efforts%20to%20eradicate%20endemic%20leprosy%20and%20prevent%20the%20emergence%20of%20drug%20resistance%20in%20afflicted%20countries.%22%2C%22date%22%3A%222018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.3389%5C%2Ffmicb.2018.03072%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.frontiersin.org%5C%2Farticles%5C%2F10.3389%5C%2Ffmicb.2018.03072%5C%2Ffull%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221664-302X%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A23%3A07Z%22%7D%7D%2C%7B%22key%22%3A%2247M4JF49%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Maitre%20et%20al.%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMaitre%2C%20T.%2C%20Robert%2C%20J.%20and%20Veziris%2C%20N.%20%282018%29.%20%26lt%3Bb%26gt%3BIntroduction%3A%20%26%23xE9%3Bpid%26%23xE9%3Bmiologie%20de%20la%20tuberculose%20et%20de%20l%26%23x2019%3Binfection%20tuberculeuse%20latente%26lt%3B%5C%2Fb%26gt%3B.%20Rev%20Mal%20Respir%20%26lt%3Bi%26gt%3B35%26lt%3B%5C%2Fi%26gt%3B%2C%20859%26%23x2013%3B861%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2018.08.009%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.rmr.2018.08.009%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Introduction%3A%20%5Cu00e9pid%5Cu00e9miologie%20de%20la%20tuberculose%20et%20de%20l%27infection%20tuberculeuse%20latente%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22T%22%2C%22lastName%22%3A%22Maitre%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N%22%2C%22lastName%22%3A%22Veziris%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%222018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.rmr.2018.08.009%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.em-consulte.com%5C%2Frmr%5C%2Farticle%5C%2F1249352%5C%2F%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22FR%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-01T15%3A58%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22AILCSCWE%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mieras%20et%20al.%22%2C%22parsedDate%22%3A%222018-10-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMieras%2C%20L.%20F.%2C%20Taal%2C%20A.%20T.%2C%20van%20Brakel%2C%20W.%20H.%2C%20Cambau%2C%20E.%2C%20Saunderson%2C%20P.%20R.%2C%20Smith%2C%20W.%20C.%20S.%2C%20Prakoeswa%2C%20C.%20R.%20S.%2C%20Astari%2C%20L.%2C%20Scollard%2C%20D.%20M.%2C%20do%20Nascimento%2C%20D.%20C.%2C%20Grosset%2C%20J.%2C%20Kar%2C%20H.%20K.%2C%20Izumi%2C%20S.%2C%20Gillini%2C%20L.%2C%20Virmond%2C%20M.%20C.%20L.%20and%20Sturkenboom%2C%20M.%20G.%20G.%20%282018%29.%20%26lt%3Bb%26gt%3BAn%20enhanced%20regimen%20as%20post-exposure%20chemoprophylaxis%20for%20leprosy%3A%20PEP%2B%2B%26lt%3B%5C%2Fb%26gt%3B.%20BMC%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B18%26lt%3B%5C%2Fi%26gt%3B%2C%20506%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-018-3402-4%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-018-3402-4%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22An%20enhanced%20regimen%20as%20post-exposure%20chemoprophylaxis%20for%20leprosy%3A%20PEP%2B%2B%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Liesbeth%20F.%22%2C%22lastName%22%3A%22Mieras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20T.%22%2C%22lastName%22%3A%22Taal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wim%20H.%22%2C%22lastName%22%3A%22van%20Brakel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20R.%22%2C%22lastName%22%3A%22Saunderson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20Cairns%20S.%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cita%20Rosita%20S.%22%2C%22lastName%22%3A%22Prakoeswa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Linda%22%2C%22lastName%22%3A%22Astari%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Scollard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dejair%20Caitano%22%2C%22lastName%22%3A%22do%20Nascimento%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacques%22%2C%22lastName%22%3A%22Grosset%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hemanta%20K.%22%2C%22lastName%22%3A%22Kar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shinzo%22%2C%22lastName%22%3A%22Izumi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laura%22%2C%22lastName%22%3A%22Gillini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcos%20C.%20L.%22%2C%22lastName%22%3A%22Virmond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marieke%20G.%20G.%22%2C%22lastName%22%3A%22Sturkenboom%22%7D%5D%2C%22abstractNote%22%3A%22The%20ongoing%20transmission%20of%20Mycobacterium%20%28M.%29%20leprae%20reflected%20in%20a%20very%20slow%20decline%20in%20leprosy%20incidence%2C%20forces%20us%20to%20be%20innovative%20and%20conduct%20cutting-edge%20research.%20Single%20dose%20rifampicin%20%28SDR%29%20as%20post-exposure%20prophylaxis%20%28PEP%29%20for%20contacts%20of%20leprosy%20patients%2C%20reduces%20their%20risk%20to%20develop%20leprosy%20by%2060%25.%20This%20is%20a%20promising%20new%20preventive%20measure%20that%20can%20be%20integrated%20into%20routine%20leprosy%20control%20programmes%2C%20as%20is%20being%20demonstrated%20in%20the%20Leprosy%20Post-Exposure%20Programme%20that%20is%20currently%20ongoing%20in%20eight%20countries.%22%2C%22date%22%3A%22October%205%2C%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12879-018-3402-4%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12879-018-3402-4%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221471-2334%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A26%3A45Z%22%7D%7D%2C%7B%22key%22%3A%22CTA5ZE65%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Rueda%20et%20al.%22%2C%22parsedDate%22%3A%222018-03%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BRueda%2C%20D.%2C%20Bernard%2C%20C.%2C%20Gandy%2C%20L.%2C%20Capton%2C%20E.%2C%20Boudjelloul%2C%20R.%2C%20Brossier%2C%20F.%2C%20Veziris%2C%20N.%2C%20Zimic%2C%20M.%20and%20Sougakoff%2C%20W.%20%282018%29.%20%26lt%3Bb%26gt%3BEstimation%20of%20pyrazinamidase%20activity%20using%20a%20cell-free%20In%20vitro%20synthesis%20of%20pnca%20and%20its%20association%20with%20pyrazinamide%20susceptibility%20in%20Mycobacterium%20tuberculosis%26lt%3B%5C%2Fb%26gt%3B.%20Int%20J%20Mycobacteriol%20%26lt%3Bi%26gt%3B7%26lt%3B%5C%2Fi%26gt%3B%2C%2016%26%23x2013%3B25%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4103%5C%2Fijmy.ijmy_187_17%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.4103%5C%2Fijmy.ijmy_187_17%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimation%20of%20pyrazinamidase%20activity%20using%20a%20cell-free%20In%20vitro%20synthesis%20of%20pnca%20and%20its%20association%20with%20pyrazinamide%20susceptibility%20in%20Mycobacterium%20tuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Rueda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christine%22%2C%22lastName%22%3A%22Bernard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lucas%22%2C%22lastName%22%3A%22Gandy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Estelle%22%2C%22lastName%22%3A%22Capton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachid%22%2C%22lastName%22%3A%22Boudjelloul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mirko%22%2C%22lastName%22%3A%22Zimic%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20The%20main%20mechanism%20of%20resistance%20to%20PZA%20in%20Mycobacterium%20tuberculosis%20relies%20on%20mutations%20on%20its%20pyrazinamidase%5C%2Fnicotinamidase.%20Recently%2C%20a%20rapid%20colorimetric%20test%20relying%20on%20the%20PCR-based%20in%20vitro-synthesized-PZase%20assay%20has%20been%20reported%20for%20PZase%20activity%20determination%20from%20clinical%20M.%20tuberculosis%20isolates%20but%20the%20assay%20has%20not%20been%20compared%20with%20other%20tests%20to%20evaluate%20PZA%20susceptibility%20in%20M.%20tuberculosis%20isolates.%5CnMethods%3A%20In%20this%20study%2C%20we%20have%20used%20the%20PCR-based%20in%20vitro-synthesized-PZase%20assay%20to%20analyze%20the%20specific%20pyrazinamidase%20%28PZase%29%20activity%20of%20PncA%20mutants%20and%20have%20correlated%20the%20results%20to%20the%20PZA%20susceptibility%20phenotype%20determined%20by%20culture%20in%20acidic%20agar%20medium%20at%20pH%206.0.%20A%20set%20of%2023%20clinical%20isolates%20displaying%20mutated%20pncA%20genes%20%2811%20PZA-resistant%20and%2012%20PZA-susceptible%29%20and%2055%20PZA-susceptible%20clinical%20strains%20displaying%20a%20wild-type%20pncA%20gene%20were%20tested.%5CnResults%3A%20Among%20the%2023%20mutants%20tested%2C%204%20corresponded%20to%20mutations%20not%20reported%20before%20%28I5T%2C%20Y99S%2C%20T142R%20and%20P77L%2BV131G%29.%20Of%20the%2011%20PncA%20mutants%20expressed%20from%20PZA-resistant%20clinical%20isolates%2C%209%20were%20expressed%20in%20vitro%20at%20yields%20%26gt%3B%2050%25%20relative%20to%20the%20wild%20type%20enzyme.%20Among%20them%2C%206%20enzymes%20%28T47P%2C%20H51P%2C%20H51R%2C%20H57D%2C%20L85R%20and%20T142R%29%20showed%20no%20detectable%20activity%2C%20while%20the%20relative%20activities%20for%20the%203%20others%2C%20V9A%20%2827%25%29%2C%20G97D%20%2810%25%29%20and%20A146V%20%2828%25%29%20were%20low%20compared%20to%20the%20wild-type%20PZase.%20The%20remaining%20two%20mutants%2C%20I5T%20and%20V9G%2C%20presented%20very%20low%20relative%20expression%20%285%25%29%20and%20relative%20activities%20values%20of%2012%20and%201%25%2C%20respectively.%20Twelve%20mutants%20were%20expressed%20from%20PZA-susceptible%20isolates.%20Their%20expression%20was%20similar%20to%20the%20wild%20type%20enzyme%20and%20behaved%20as%20active%20pyrazinamidase%20with%20specific%20relative%20activities%20ranging%20from%2034%20to%20314%25.%20Finally%2C%20discrepant%20results%20were%20observed%20for%20two%20mutants%2C%20V7A%20and%20P62T.%5CnConclusion%3A%20Thus%2C%20this%20study%20provides%20the%20proof%20of%20concept%20that%20the%20PCR-based%20in%20vitro-synthesized-PZase%20assay%20represents%20a%20promising%20rapid%20approach%20for%20the%20evaluation%20of%20PZA%20susceptibility%20based%20on%20the%20estimation%20of%20the%20relative%20PZase%20activity%20from%20clinical%20isolates.%22%2C%22date%22%3A%222018%20Jan-Mar%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.4103%5C%2Fijmy.ijmy_187_17%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222212-554X%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A40%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22UVNQA65L%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Sayes%20et%20al.%22%2C%22parsedDate%22%3A%222018-04-24%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BSayes%2C%20F.%2C%20Blanc%2C%20C.%2C%20Ates%2C%20L.%20S.%2C%20Deboosere%2C%20N.%2C%20Orgeur%2C%20M.%2C%20Le%20Chevalier%2C%20F.%2C%20Gr%26%23xF6%3Bschel%2C%20M.%20I.%2C%20Frigui%2C%20W.%2C%20Song%2C%20O.-R.%2C%20Lo-Man%2C%20R.%2C%20Brossier%2C%20F.%2C%20Sougakoff%2C%20W.%2C%20Bottai%2C%20D.%2C%20Brodin%2C%20P.%2C%20Charneau%2C%20P.%2C%20Brosch%2C%20R.%20and%20Majlessi%2C%20L.%20%282018%29.%20%26lt%3Bb%26gt%3BMultiplexed%20Quantitation%20of%20Intraphagocyte%20Mycobacterium%20tuberculosis%20Secreted%20Protein%20Effectors%26lt%3B%5C%2Fb%26gt%3B.%20Cell%20Reports%20%26lt%3Bi%26gt%3B23%26lt%3B%5C%2Fi%26gt%3B%2C%201072%26%23x2013%3B1084%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.celrep.2018.03.125%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.celrep.2018.03.125%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Multiplexed%20Quantitation%20of%20Intraphagocyte%20Mycobacterium%20tuberculosis%20Secreted%20Protein%20Effectors%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fadel%22%2C%22lastName%22%3A%22Sayes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Blanc%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Louis%20S.%22%2C%22lastName%22%3A%22Ates%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nathalie%22%2C%22lastName%22%3A%22Deboosere%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mickael%22%2C%22lastName%22%3A%22Orgeur%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fabien%22%2C%22lastName%22%3A%22Le%20Chevalier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%20I.%22%2C%22lastName%22%3A%22Gr%5Cu00f6schel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wafa%22%2C%22lastName%22%3A%22Frigui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ok-Ryul%22%2C%22lastName%22%3A%22Song%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Lo-Man%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Florence%22%2C%22lastName%22%3A%22Brossier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daria%22%2C%22lastName%22%3A%22Bottai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Priscille%22%2C%22lastName%22%3A%22Brodin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pierre%22%2C%22lastName%22%3A%22Charneau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Roland%22%2C%22lastName%22%3A%22Brosch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Laleh%22%2C%22lastName%22%3A%22Majlessi%22%7D%5D%2C%22abstractNote%22%3A%22Summary%5CnThe%20pathogenic%20potential%20of%20Mycobacterium%20tuberculosis%20largely%20depends%20on%20ESX%20secretion%20systems%20exporting%20members%20of%20the%20multigenic%20Esx%2C%20Esp%2C%20and%20PE%5C%2FPPE%20protein%20families.%20To%20study%20the%20secretion%20and%5Cu00a0regulation%20patterns%20of%20these%20proteins%20while%20circumventing%20immune%20cross-reactions%20due%20to%20their%20extensive%20sequence%20homologies%2C%20we%20developed%20an%20approach%20that%20relies%20on%20the%20recognition%20of%20their%20MHC%20class%20II%20epitopes%20by%20highly%20discriminative%20T%5Cu00a0cell%20receptors%20%28TCRs%29%20of%20a%20panel%20of%20T%5Cu00a0cell%20hybridomas.%20The%20latter%20were%20engineered%20so%20that%20each%20expresses%20a%20unique%20fluorescent%20reporter%20linked%20to%20specific%20antigen%20recognition.%20The%20resulting%20polychromatic%20and%20multiplexed%20imaging%20assay%20enabled%20us%20to%20measure%20the%20secretion%20of%20mycobacterial%20effectors%20inside%20infected%20host%20cells.%5Cu00a0We%20applied%20this%20novel%20technology%20to%20a%20large%20panel%20of%20mutants%2C%20clinical%20isolates%2C%20and%20host-cell%20types%20to%20explore%20the%20host-mycobacteria%20interplay%20and%20its%20impact%20on%20the%20intracellular%20bacterial%20secretome%2C%20which%20also%20revealed%20the%20unexpected%20capacity%20of%20phagocytes%20from%20lung%20granuloma%20to%20present%20mycobacterial%20antigens%20via%20MHC%20class%20II.%22%2C%22date%22%3A%22April%2024%2C%202018%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.celrep.2018.03.125%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22http%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS2211124718305011%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222211-1247%22%2C%22language%22%3A%22%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-05T14%3A57%3A50Z%22%7D%7D%2C%7B%22key%22%3A%22I3MSQAQL%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Scherr%20et%20al.%22%2C%22parsedDate%22%3A%222018-12-18%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BScherr%2C%20N.%2C%20Bieri%2C%20R.%2C%20Thomas%2C%20S.%20S.%2C%20Chauffour%2C%20A.%2C%20Kalia%2C%20N.%20P.%2C%20Schneide%2C%20P.%2C%20Ruf%2C%20M.-T.%2C%20Lamelas%2C%20A.%2C%20Manimekalai%2C%20M.%20S.%20S.%2C%20Gr%26%23xFC%3Bber%2C%20G.%2C%20Ishii%2C%20N.%2C%20Suzuki%2C%20K.%2C%20Tanner%2C%20M.%2C%20Moraski%2C%20G.%20C.%2C%20Miller%2C%20M.%20J.%2C%20Witschel%2C%20M.%2C%20Jarlier%2C%20V.%2C%20Pluschke%2C%20G.%20and%20Pethe%2C%20K.%20%282018%29.%20%26lt%3Bb%26gt%3BTargeting%20the%20Mycobacterium%20ulcerans%20cytochrome%20bc%201%26%23x202F%3B%3A%20aa%203%20for%20the%20treatment%20of%20Buruli%20ulcer%26lt%3B%5C%2Fb%26gt%3B.%20Nature%20Communications%20%26lt%3Bi%26gt%3B9%26lt%3B%5C%2Fi%26gt%3B%2C%205370%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-018-07804-8%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41467-018-07804-8%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20the%20Mycobacterium%20ulcerans%20cytochrome%20bc%201%20%3A%20aa%203%20for%20the%20treatment%20of%20Buruli%20ulcer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicole%22%2C%22lastName%22%3A%22Scherr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raphael%22%2C%22lastName%22%3A%22Bieri%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sangeeta%20S.%22%2C%22lastName%22%3A%22Thomas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aur%5Cu00e9lie%22%2C%22lastName%22%3A%22Chauffour%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nitin%20Pal%22%2C%22lastName%22%3A%22Kalia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Schneide%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-Th%5Cu00e9r%5Cu00e8se%22%2C%22lastName%22%3A%22Ruf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Araceli%22%2C%22lastName%22%3A%22Lamelas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Malathy%20S.%20S.%22%2C%22lastName%22%3A%22Manimekalai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerhard%22%2C%22lastName%22%3A%22Gr%5Cu00fcber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Norihisa%22%2C%22lastName%22%3A%22Ishii%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Koichi%22%2C%22lastName%22%3A%22Suzuki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Tanner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Garrett%20C.%22%2C%22lastName%22%3A%22Moraski%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marvin%20J.%22%2C%22lastName%22%3A%22Miller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Witschel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%22%2C%22lastName%22%3A%22Jarlier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerd%22%2C%22lastName%22%3A%22Pluschke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%22%2C%22lastName%22%3A%22Pethe%22%7D%5D%2C%22abstractNote%22%3A%22Mycobacterium%20ulcerans%20is%20the%20causative%20agent%20of%20Buruli%20ulcer%20%28BU%29.%20Existing%20anti-tubercular%20drugs%20have%20been%20used%20to%20treat%20the%20condition%20with%20varying%20success.%20Here%2C%20the%20authors%20show%20that%20a%20clinical-stage%20drug%20candidate%20for%20tuberculosis%2C%20Q203%2C%20is%20effective%20at%20killing%20M.%20ulcerans%20and%20is%20a%20promising%20therapeutic%20candidate%20for%20BU.%22%2C%22date%22%3A%222018-12-18%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41467-018-07804-8%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41467-018-07804-8%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222041-1723%22%2C%22language%22%3A%22En%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-05T14%3A56%3A21Z%22%7D%7D%2C%7B%22key%22%3A%22W8ZZK3DJ%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22van%20Ingen%20et%20al.%22%2C%22parsedDate%22%3A%222018-03-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3Bvan%20Ingen%2C%20J.%2C%20Aksamit%2C%20T.%2C%20Andrejak%2C%20C.%2C%20B%26%23xF6%3Bttger%2C%20E.%20C.%2C%20Cambau%2C%20E.%2C%20Daley%2C%20C.%20L.%2C%20Griffith%2C%20D.%20E.%2C%20Guglielmetti%2C%20L.%2C%20Holland%2C%20S.%20M.%2C%20Huitt%2C%20G.%20A.%2C%20Koh%2C%20W.-J.%2C%20Lange%2C%20C.%2C%20Leitman%2C%20P.%2C%20Marras%2C%20T.%20K.%2C%20Morimoto%2C%20K.%2C%20Olivier%2C%20K.%20N.%2C%20Santin%2C%20M.%2C%20Stout%2C%20J.%20E.%2C%20Thomson%2C%20R.%2C%20Tortoli%2C%20E.%2C%20Wallace%2C%20R.%20J.%2C%20Winthrop%2C%20K.%20L.%20and%20Wagner%2C%20D.%20%282018%29.%20%26lt%3Bb%26gt%3BTreatment%20outcome%20definitions%20in%20nontuberculous%20mycobacterial%20pulmonary%20disease%3A%20an%20NTM-NET%20consensus%20statement%26lt%3B%5C%2Fb%26gt%3B.%20European%20Respiratory%20Journal%20%26lt%3Bi%26gt%3B51%26lt%3B%5C%2Fi%26gt%3B%2C%201800170%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00170-2018%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1183%5C%2F13993003.00170-2018%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Treatment%20outcome%20definitions%20in%20nontuberculous%20mycobacterial%20pulmonary%20disease%3A%20an%20NTM-NET%20consensus%20statement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%22%2C%22lastName%22%3A%22van%20Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%22%2C%22lastName%22%3A%22Aksamit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claire%22%2C%22lastName%22%3A%22Andrejak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emmanuelle%22%2C%22lastName%22%3A%22Cambau%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Charles%20L.%22%2C%22lastName%22%3A%22Daley%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20E.%22%2C%22lastName%22%3A%22Griffith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lorenzo%22%2C%22lastName%22%3A%22Guglielmetti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20M.%22%2C%22lastName%22%3A%22Holland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gwen%20A.%22%2C%22lastName%22%3A%22Huitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Won-Jung%22%2C%22lastName%22%3A%22Koh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philip%22%2C%22lastName%22%3A%22Leitman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Theodore%20K.%22%2C%22lastName%22%3A%22Marras%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kozo%22%2C%22lastName%22%3A%22Morimoto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%20N.%22%2C%22lastName%22%3A%22Olivier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Miguel%22%2C%22lastName%22%3A%22Santin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%20E.%22%2C%22lastName%22%3A%22Stout%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rachel%22%2C%22lastName%22%3A%22Thomson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enrico%22%2C%22lastName%22%3A%22Tortoli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20J.%22%2C%22lastName%22%3A%22Wallace%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kevin%20L.%22%2C%22lastName%22%3A%22Winthrop%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%22%2C%22lastName%22%3A%22Wagner%22%7D%5D%2C%22abstractNote%22%3A%22Tweetable%20abstract%20%40ERSpublications%5Cnclick%20to%20tweetImproving%20treatment%20outcome%20reporting%20in%20NTM%20disease%3A%20NTM-NET%20%28%40ntmnet%29%20consensus%20statement%20on%20treatment%20outcome%20definitions%20http%3A%5C%2F%5C%2Fow.ly%5C%2Fc6IC30iwLM4%22%2C%22date%22%3A%222018%5C%2F03%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1183%5C%2F13993003.00170-2018%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Ferj.ersjournals.com%5C%2Fcontent%5C%2F51%5C%2F3%5C%2F1800170%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%220903-1936%2C%201399-3003%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-05T14%3A58%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22TBBJFYPR%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Walker%20et%20al.%22%2C%22parsedDate%22%3A%222018-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWalker%2C%20T.%20M.%2C%20Merker%2C%20M.%2C%20Knoblauch%2C%20A.%20M.%2C%20Helbling%2C%20P.%2C%20Schoch%2C%20O.%20D.%2C%20Werf%2C%20M.%20J.%20van%20der%2C%20Kranzer%2C%20K.%2C%20Fiebig%2C%20L.%2C%20Kr%26%23xF6%3Bger%2C%20S.%2C%20Haas%2C%20W.%2C%20Hoffmann%2C%20H.%2C%20Indra%2C%20A.%2C%20Egli%2C%20A.%2C%20Cirillo%2C%20D.%20M.%2C%20Robert%2C%20J.%2C%20Rogers%2C%20T.%20R.%2C%20Groenheit%2C%20R.%2C%20Mengshoel%2C%20A.%20T.%2C%20Mathys%2C%20V.%2C%20Haanper%26%23xE4%3B%2C%20M.%2C%20Soolingen%2C%20D.%20van%2C%20Niemann%2C%20S.%2C%20B%26%23xF6%3Bttger%2C%20E.%20C.%2C%20Keller%2C%20P.%20M.%2C%20Avsar%2C%20K.%2C%20Bauer%2C%20C.%2C%20Bernasconi%2C%20E.%2C%20Borroni%2C%20E.%2C%20Brusin%2C%20S.%2C%20D%26%23xE9%3Bvis%2C%20M.%20C.%2C%20Crook%2C%20D.%20W.%2C%20Dedicoat%2C%20M.%2C%20Fitzgibbon%2C%20M.%2C%20Gagneux%2C%20S.%2C%20Geiger%2C%20F.%2C%20Guthmann%2C%20J.-P.%2C%20Hendrickx%2C%20D.%2C%20Hoffmann-Thiel%2C%20S.%2C%20Ingen%2C%20J.%20van%2C%20Jackson%2C%20S.%2C%20Jaton%2C%20K.%2C%20Lange%2C%20C.%2C%20Stalder%2C%20J.%20M.%2C%20O%26%23x2019%3BDonnell%2C%20J.%2C%20Opota%2C%20O.%2C%20Peto%2C%20T.%20E.%20A.%2C%20Preiswerk%2C%20B.%2C%20Roycroft%2C%20E.%2C%20Sato%2C%20M.%2C%20Schacher%2C%20R.%2C%20Schulthess%2C%20B.%2C%20Smith%2C%20E.%20G.%2C%20Soini%2C%20H.%2C%20Sougakoff%2C%20W.%2C%20Tagliani%2C%20E.%2C%20Utpatel%2C%20C.%2C%20Veziris%2C%20N.%2C%20Wagner-Wiening%2C%20C.%20and%20Witschi%2C%20M.%20%282018%29.%20%26lt%3Bb%26gt%3BA%20cluster%20of%20multidrug-resistant%20Mycobacterium%20tuberculosis%20among%20patients%20arriving%20in%20Europe%20from%20the%20Horn%20of%20Africa%3A%20a%20molecular%20epidemiological%20study%26lt%3B%5C%2Fb%26gt%3B.%20The%20Lancet%20Infectious%20Diseases%20%26lt%3Bi%26gt%3B18%26lt%3B%5C%2Fi%26gt%3B%2C%20431%26%23x2013%3B440%2C%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2818%2930004-5%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS1473-3099%2818%2930004-5%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22A%20cluster%20of%20multidrug-resistant%20Mycobacterium%20tuberculosis%20among%20patients%20arriving%20in%20Europe%20from%20the%20Horn%20of%20Africa%3A%20a%20molecular%20epidemiological%20study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Timothy%20M.%22%2C%22lastName%22%3A%22Walker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthias%22%2C%22lastName%22%3A%22Merker%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Astrid%20M.%22%2C%22lastName%22%3A%22Knoblauch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%22%2C%22lastName%22%3A%22Helbling%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Otto%20D.%22%2C%22lastName%22%3A%22Schoch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marieke%20J.%20van%20der%22%2C%22lastName%22%3A%22Werf%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katharina%22%2C%22lastName%22%3A%22Kranzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lena%22%2C%22lastName%22%3A%22Fiebig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Kr%5Cu00f6ger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Walter%22%2C%22lastName%22%3A%22Haas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Harald%22%2C%22lastName%22%3A%22Hoffmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alexander%22%2C%22lastName%22%3A%22Indra%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%22%2C%22lastName%22%3A%22Egli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniela%20M.%22%2C%22lastName%22%3A%22Cirillo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J%5Cu00e9r%5Cu00f4me%22%2C%22lastName%22%3A%22Robert%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Thomas%20R.%22%2C%22lastName%22%3A%22Rogers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ramona%22%2C%22lastName%22%3A%22Groenheit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anne%20T.%22%2C%22lastName%22%3A%22Mengshoel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Mathys%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marjo%22%2C%22lastName%22%3A%22Haanper%5Cu00e4%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dick%20van%22%2C%22lastName%22%3A%22Soolingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stefan%22%2C%22lastName%22%3A%22Niemann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Erik%20C.%22%2C%22lastName%22%3A%22B%5Cu00f6ttger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20M.%22%2C%22lastName%22%3A%22Keller%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Korkut%22%2C%22lastName%22%3A%22Avsar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Enos%22%2C%22lastName%22%3A%22Bernasconi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emanuele%22%2C%22lastName%22%3A%22Borroni%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sergio%22%2C%22lastName%22%3A%22Brusin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mireia%20Coscoll%5Cu00e1%22%2C%22lastName%22%3A%22D%5Cu00e9vis%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Derrick%20W.%22%2C%22lastName%22%3A%22Crook%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%22%2C%22lastName%22%3A%22Dedicoat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Margaret%22%2C%22lastName%22%3A%22Fitzgibbon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22S%5Cu00e9bastien%22%2C%22lastName%22%3A%22Gagneux%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Francisca%22%2C%22lastName%22%3A%22Geiger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Paul%22%2C%22lastName%22%3A%22Guthmann%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Hendrickx%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabine%22%2C%22lastName%22%3A%22Hoffmann-Thiel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jakko%20van%22%2C%22lastName%22%3A%22Ingen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sarah%22%2C%22lastName%22%3A%22Jackson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Katia%22%2C%22lastName%22%3A%22Jaton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%22%2C%22lastName%22%3A%22Lange%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jessica%20Mazza%22%2C%22lastName%22%3A%22Stalder%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joan%22%2C%22lastName%22%3A%22O%27Donnell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Onya%22%2C%22lastName%22%3A%22Opota%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%20E.%20A.%22%2C%22lastName%22%3A%22Peto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%22%2C%22lastName%22%3A%22Preiswerk%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emma%22%2C%22lastName%22%3A%22Roycroft%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariko%22%2C%22lastName%22%3A%22Sato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Regina%22%2C%22lastName%22%3A%22Schacher%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bettina%22%2C%22lastName%22%3A%22Schulthess%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22E.%20Grace%22%2C%22lastName%22%3A%22Smith%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hanna%22%2C%22lastName%22%3A%22Soini%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wladimir%22%2C%22lastName%22%3A%22Sougakoff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Elisa%22%2C%22lastName%22%3A%22Tagliani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christian%22%2C%22lastName%22%3A%22Utpatel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Veziris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christiane%22%2C%22lastName%22%3A%22Wagner-Wiening%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Witschi%22%7D%5D%2C%22abstractNote%22%3A%22%26lt%3Bh2%26gt%3BSummary%26lt%3B%5C%2Fh2%26gt%3B%26lt%3Bh3%26gt%3BBackground%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BThe%20risk%20of%20tuberculosis%20outbreaks%20among%20people%20fleeing%20hardship%20for%20refuge%20in%20Europe%20is%20heightened.%20We%20describe%20the%20cross-border%20European%20response%20to%20an%20outbreak%20of%20multidrug-resistant%20tuberculosis%20among%20patients%20from%20the%20Horn%20of%20Africa%20and%20Sudan.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BMethods%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BOn%20April%2029%20and%20May%2030%2C%202016%2C%20the%20Swiss%20and%20German%20National%20Mycobacterial%20Reference%20Laboratories%20independently%20triggered%20an%20outbreak%20investigation%20after%20four%20patients%20were%20diagnosed%20with%20multidrug-resistant%20tuberculosis.%20In%20this%20molecular%20epidemiological%20study%2C%20we%20prospectively%20defined%20outbreak%20cases%20with%2024-locus%20mycobacterial%20interspersed%20repetitive%20unit-variable%20number%20tandem%20repeat%20%28MIRU-VNTR%29%20profiles%3B%20phenotypic%20resistance%20to%20isoniazid%2C%20rifampicin%2C%20ethambutol%2C%20pyrazinamide%2C%20and%20capreomycin%3B%20and%20corresponding%20drug%20resistance%20mutations.%20We%20whole-genome%20sequenced%20all%20%26lt%3Bi%26gt%3BMycobacterium%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%20isolates%20and%20clustered%20them%20using%20a%20threshold%20of%20five%20single%20nucleotide%20polymorphisms%20%28SNPs%29.%20We%20collated%20epidemiological%20data%20from%20host%20countries%20from%20the%20European%20Centre%20for%20Disease%20Prevention%20and%20Control.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BFindings%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BBetween%20Feb%2012%2C%202016%2C%20and%20April%2019%2C%202017%2C%2029%20patients%20were%20diagnosed%20with%20multidrug-resistant%20tuberculosis%20in%20seven%20European%20countries.%20All%20originated%20from%20the%20Horn%20of%20Africa%20or%20Sudan%2C%20with%20all%20isolates%20two%20SNPs%20or%20fewer%20apart.%2022%20%2876%25%29%20patients%20reported%20their%20travel%20routes%2C%20with%20clear%20spatiotemporal%20overlap%20between%20routes.%20We%20identified%20a%20further%2029%20MIRU-VNTR-linked%20cases%20from%20the%20Horn%20of%20Africa%20that%20predated%20the%20outbreak%2C%20but%20all%20were%20more%20than%20five%20SNPs%20from%20the%20outbreak.%20However%20all%2058%20isolates%20shared%20a%20capreomycin%20resistance-associated%20%26lt%3Bi%26gt%3BtlyA%26lt%3B%5C%2Fi%26gt%3B%20mutation.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BInterpretation%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BOur%20data%20suggest%20that%20source%20cases%20are%20linked%20to%20an%20%26lt%3Bi%26gt%3BM%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%20clone%20circulating%20in%20northern%20Somalia%20or%20Djibouti%20and%20that%20transmission%20probably%20occurred%20en%20route%20before%20arrival%20in%20Europe.%20We%20hypothesise%20that%20the%20shared%20mutation%20of%20%26lt%3Bi%26gt%3BtlyA%26lt%3B%5C%2Fi%26gt%3B%20is%20a%20drug%20resistance%20mutation%20and%20phylogenetic%20marker%2C%20the%20first%20of%20its%20kind%20in%20%26lt%3Bi%26gt%3BM%20tuberculosis%26lt%3B%5C%2Fi%26gt%3B%20sensu%20stricto.%26lt%3B%5C%2Fp%26gt%3B%26lt%3Bh3%26gt%3BFunding%26lt%3B%5C%2Fh3%26gt%3B%26lt%3Bp%26gt%3BThe%20Swiss%20Federal%20Office%20of%20Public%20Health%2C%20the%20University%20of%20Zurich%2C%20the%20Wellcome%20Trust%2C%20National%20Institute%20for%20Health%20Research%20%28NIHR%29%20Oxford%20Biomedical%20Research%20Centre%20%28BRC%29%2C%20the%20Medical%20Research%20Council%2C%20BELTA-TBnet%2C%20the%20European%20Union%2C%20the%20German%20Center%20for%20Infection%20Research%2C%20and%20Leibniz%20Science%20Campus%20Evolutionary%20Medicine%20of%20the%20Lung%20%28EvoLUNG%29.%26lt%3B%5C%2Fp%26gt%3B%22%2C%22date%22%3A%222018%5C%2F04%5C%2F01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2FS1473-3099%2818%2930004-5%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.thelancet.com%5C%2Fjournals%5C%2Flaninf%5C%2Farticle%5C%2FPIIS1473-3099%2818%2930004-5%5C%2Fabstract%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221473-3099%2C%201474-4457%22%2C%22language%22%3A%22English%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222019-04-03T22%3A41%3A07Z%22%7D%7D%2C%7B%22key%22%3A%22JGR9A936%22%2C%22library%22%3A%7B%22id%22%3A1368488%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22World%20Health%20Organization%22%2C%22parsedDate%22%3A%222018%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BWorld%20Health%20Organization%20%282018%29.%20Technical%20Report%20on%5Cncritical%20concentrations%5Cnfor%20drug%20susceptibility%20testing%5Cnof%20medicines%20used%20in%20the%5Cntreatment%20of%20drug-resistant%5Cntuberculosis%2C%20WHO%2C%20Geneva%2C%20URL%3A%20%26lt%3Ba%20class%3D%26%23039%3Bzp-ItemURL%26%23039%3B%20target%3D%26%23039%3B_blank%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fapps.who.int%5C%2Firis%5C%2Frest%5C%2Fbitstreams%5C%2F1098393%5C%2Fretrieve%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fapps.who.int%5C%2Firis%5C%2Frest%5C%2Fbitstreams%5C%2F1098393%5C%2Fretrieve%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22report%22%2C%22title%22%3A%22Technical%20Report%20on%5Cncritical%20concentrations%5Cnfor%20drug%20susceptibility%20testing%5Cnof%20medicines%20used%20in%20the%5Cntreatment%20of%20drug-resistant%5Cntuberculosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22%22%2C%22lastName%22%3A%22World%20Health%20Organization%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22reportNumber%22%3A%22WHO%5C%2FCDS%5C%2FTB%5C%2F2018.5%22%2C%22reportType%22%3A%22%22%2C%22institution%22%3A%22WHO%22%2C%22date%22%3A%222018%22%2C%22DOI%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fapps.who.int%5C%2Firis%5C%2Frest%5C%2Fbitstreams%5C%2F1098393%5C%2Fretrieve%22%2C%22ISSN%22%3A%22%22%2C%22language%22%3A%22EN%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222022-03-16T23%3A19%3A49Z%22%7D%7D%5D%7D
Ahmad, N., Ahuja, S. D., Akkerman, O. W., Alffenaar, J.-W. C., Anderson, L. F., Baghaei, P., Bang, D., Barry, P. M., Bastos, M. L., Behera, D., Benedetti, A., Bisson, G. P., Boeree, M. J., Bonnet, M., Brode, S. K., Brust, J. C. M., Cai, Y., Caumes, E., Cegielski, J. P., Centis, R., Chan, P.-C., Chan, E. D., Chang, K.-C., Charles, M., Cirule, A., Dalcolmo, M. P., D’Ambrosio, L., de Vries, G., Dheda, K., Esmail, A., Flood, J., Fox, G. J., Fréchet-Jachym, M., Fregona, G., Gayoso, R., Gegia, M., Gler, M. T., Gu, S., Guglielmetti, L., Holtz, T. H., Hughes, J., Isaakidis, P., Jarlsberg, L., Kempker, R. R., Keshavjee, S., Khan, F. A., Kipiani, M., Koenig, S. P., Koh, W.-J., Kritski, A., Kuksa, L., Kvasnovsky, C. L., Kwak, N., Lan, Z., Lange, C., Laniado-Laborín, R., Lee, M., Leimane, V., Leung, C.-C., Leung, E. C.-C., Li, P. Z., Lowenthal, P., Maciel, E. L., Marks, S. M., Mase, S., Mbuagbaw, L., Migliori, G. B., Milanov, V., Miller, A. C., Mitnick, C. D., Modongo, C., Mohr, E., Monedero, I., Nahid, P., Ndjeka, N., O’Donnell, M. R., Padayatchi, N., Palmero, D., Pape, J. W., Podewils, L. J., Reynolds, I., Riekstina, V., Robert, J., Rodriguez, M., Seaworth, B., Seung, K. J., Schnippel, K., Shim, T. S., Singla, R., Smith, S. E., Sotgiu, G., Sukhbaatar, G., Tabarsi, P., Tiberi, S., Trajman, A., Trieu, L., Udwadia, Z. F., van der Werf, T. S., Veziris, N., Viiklepp, P., Vilbrun, S. C., Walsh, K., Westenhouse, J., Yew, W.-W., Yim, J.-J., Zetola, N. M., Zignol, M. and Menzies, D. (2018). Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet 392, 821–834, http://doi.org/10.1016/S0140-6736(18)31644-1.
Ates, L. S., Dippenaar, A., Sayes, F., Pawlik, A., Bouchier, C., Ma, L., Warren, R. M., Sougakoff, W., Majlessi, L., van Heijst, J. W. J., Brossier, F. and Brosch, R. (2018). Unexpected Genomic and Phenotypic Diversity of Mycobacterium africanum Lineage 5 Affects Drug Resistance, Protein Secretion, and Immunogenicity. Genome Biol Evol 10, 1858–1874, http://doi.org/10.1093/gbe/evy145.
Bastard, M., Guglielmetti, L., Huerga, H., Hayrapetyan, A., Khachatryan, N., Yegiazaryan, L., Faqirzai, J., Hovhannisyan, L., Varaine, F. and Hewison, C. (2018). Bedaquiline and Repurposed Drugs for Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: How Much Better Are They? Am J Respir Crit Care Med 198, 1228–1231, http://doi.org/10.1164/rccm.201801-0019LE.
Bergot, E., Abiteboul, D., Andréjak, C., Antoun, F., Barras, E., Blanc, F.-X., Bourgarit, A., Charlois-Ou, C., Delacourt, C., Dirou, S., Gerin, M., Guerin, S., Haustraete, É., Henry, B., Lucet, J.-C., Maitre, T., Morin, J., Le Palud, P., Pommelet, V., Rivoisy, C., Robert, J., Veziris, N. and Herrmann, J.-L. (2018). [Practice recommendations for the use and interpretation of interferon gamma release assays in the diagnosis of latent and active tuberculosis]. Rev Mal Respir 35, 852–858, http://doi.org/10.1016/j.rmr.2018.08.007.
Blanc, F.-X., Dirou, S., Morin, J. and Veziris, N. (2018). [Interferon gamma release assay tests for the diagnosis of active tuberculosis]. Rev Mal Respir 35, 894–899, http://doi.org/10.1016/j.rmr.2018.08.016.
Cambau, E. (2018). Antileprosy drugs: mode of action and mechanisms. In: International textbook of leprosy, URL: https://internationaltextbookofleprosy.org/chapter/anti-leprosy-drugs-modes-action-and-mechanisms-resistance-mycobacterium-leprae [Accessed May 2022].
Cambau, E., Saunderson, P., Matsuoka, M., Cole, S. T., Kai, M., Suffys, P., Rosa, P. S., Williams, D., Gupta, U. D., Lavania, M., Cardona-Castro, N., Miyamoto, Y., Hagge, D., Srikantam, A., Hongseng, W., Indropo, A., Vissa, V., Johnson, R. C., Cauchoix, B., Pannikar, V. K., Cooreman, E. a. W. D., Pemmaraju, V. R. R., Gillini, L., Kriswamati, A., Al-Samie, A. R., Issoufou, A., Tiendrebeogo, A., Kingalu, A., Randrianantoandro, A., Kumar, A., Chauffour, A., Win, A. A., Pandey, B., Agrawal, C. M., Widaningrum, C., Schmotzer, C., Kafando, C., Bhandari, C. M., Sema, C., Vidanagama, D. S., Scollard, D. M., Beyene, D., Morelo, E. F., Kassa, E. D., Ramarolahy, E. B., Claco, E., Villalon, E. E., Sidibe, F., Sakho, F., Abdoulaye, F., Guilengue, F. F., Gajete, F., Babu, G. R., Moussa, G., Thakur, G. D., Cabanos, G., Sock, G., Clugston, G., Zaidy, H., Watanabe, H., Kawuma, H. J., Mallari, I. B., Goulart, I. M. B., Ahamed, I., Subbanna, J., Houzeo, J. G., Luengu, J. N. M., Bertolli, J., Lloyd-Owen, J., Matheu, J., Brunelli, J. P., Alzate, J. C. B., Neupane, Kapil Dev, Osuga, K., Yamaguchi, K., Azam, K., Lin, K. M., Momoudu, K., Kyaw, K., Bide, L., Doanh, L. H., My, L. H., Shah, M., Kodio, M., Sidibe, M., Ebenezer, M., Grossi, M. A. de F., Balagon, M. F., Canlonon, M., Makino, M., Htoo, M. M., Ahmed, M. J., Nadine, M.-M., Roferos, F. O., Krismawati, H., Thida, M., Htoon, M. T., Neupane, K. D., Phuc, N. H. N., Van, N. H., Hai, N. P. N., Ishii, N., Soe, O., Amiel, O., Tossou, O., Konare, O., Joshi, P. L., Rao, P. V. R., Krishnamurthy, P., Brennan, P. J., Busso, P., Bhatia, R., Andrianarivelo, M. R., Ramdas, D. R., Chabi, R., Gusmao, R., DjupuriIzwardy, R., Soares, R. C. F. R., Jhadav, R., Buhrer, S., Cho, S.-N. R., Jianping, S., Lzumi, S., Barua, S., Chaitanya, S., Tiendrebeogo, S. M. R., Khang, T. H., Gillis, T. P., Mori, T., Vijayalakshmi, V., Kamara, V. D., Wei, W., Smith, W. C. S., Li, W., Lew, W., Al-Qubati, Y., Suzuki, Y. and Nanba, Y. (2018). Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15. Clinical Microbiology and Infection 24, 1305–1310, http://doi.org/10.1016/j.cmi.2018.02.022.
Chauffour, A., Lecorche, E., Reibel, F., Mougari, F., Raskine, L., Aubry, A., Jarlier, V. and Cambau, E. (2018). Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015. Clinical Microbiology and Infection 24, 1213.e5-1213.e8, http://doi.org/10.1016/j.cmi.2018.06.004.
Coolen-Allou, N., Touron, T., Belmonte, O., Gazaille, V., Andre, M., Allyn, J., Picot, S., Payet, A. and Veziris, N. (2018). Clinical, Radiological, and Microbiological Characteristics of Mycobacterium simiae Infection in 97 Patients. Antimicrobial Agents and Chemotherapy 62, e00395-18, http://doi.org/10.1128/AAC.00395-18.
D’Ambrosio, L., Bothamley, G., Caminero Luna, J. A., Duarte, R., Guglielmetti, L., Muñoz Torrico, M., Payen, M. C., Saavedra Herrera, N., Salazar Lezama, M. A., Skrahina, A., Tadolini, M., Tiberi, S., Veziris, N. and Migliori, G. B. (2018). Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond. Pulmonology 24, 132–141, http://doi.org/10.1016/j.rppnen.2017.10.005.
Gras, J., De Castro, N., Montlahuc, C., Champion, L., Scemla, A., Matignon, M., Lachâtre, M., Raskine, L., Grall, N., Peraldi, M. N. and Molina, J. M. (2018). Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area. Transplant Infectious Disease 20, e12943, http://doi.org/10.1111/tid.12943.
Griffith, D. E., Eagle, G., Thomson, R., Aksamit, T. R., Hasegawa, N., Morimoto, K., Addrizzo-Harris, D. J., O’Donnell, A. E., Marras, T. K., Flume, P. A., Loebinger, M. R., Morgan, L., Codecasa, L. R., Hill, A. T., Ruoss, S. J., Yim, J.-J., Ringshausen, F. C., Field, S. K., Philley, J. V., Wallace, R. J., van Ingen, J., Coulter, C., Nezamis, J. and Winthrop, K. L. (2018). Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med 198, 1559–1569, http://doi.org/10.1164/rccm.201807-1318OC.
Guglielmetti, L., Barkane, L., Dû, D. L., Marigot-Outtandy, D., Robert, J., Veziris, N., Yazdanpanah, Y., Kuksa, L., Caumes, E. and Fréchet-Jachym, M. (2018). Safety and efficacy of exposure to bedaquiline−delamanid in multidrug-resistant tuberculosis: a case series from France and Latvia. European Respiratory Journal 51, 1702550, http://doi.org/10.1183/13993003.02550-2017.
Guglielmetti, L., Tiberi, S., Burman, M., Kunst, H., Wejse, C., Togonidze, T., Bothamley, G. and Lange, C. (2018). QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: a Tuberculosis Network European Trialsgroup (TBnet) study. European Respiratory Journal 52, http://doi.org/10.1183/13993003.00537-2018.
Guglielmetti, L., Veziris, N., Aubry, A., Brossier, F., Bernard, C., Sougakoff, W., Jarlier, V., Robert, J. and surveillance, for the L. N. for M. (2018). Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study., doi:info:doi/10.5588/ijtld.17.0387.
Kouriba, B., Ouwe Missi Oukem-Boyer, O., Traoré, B., Touré, A., Raskine, L. and Babin, F. X. (2018). Installing biosafety level 3 containment laboratories in low- and middle-income countries: challenges and prospects from Mali’s experience. New Microbes New Infect 26, S74–S77, http://doi.org/10.1016/j.nmni.2018.05.011.
Lecorche, E., Haenn, S., Mougari, F., Kumanski, S., Veziris, N., Benmansour, H., Raskine, L., Moulin, L., Cambau, E., Aubry, A., Brossier, F., Chauffour, A., Jaffre, J., Jarlier, V., Robert, J. and Sougakoff, W. (2018). Comparison of methods available for identification of Mycobacterium chimaera. Clinical Microbiology and Infection 24, 409–413, http://doi.org/10.1016/j.cmi.2017.07.031.
Levi, L. I., Schlemmer, F., de Castro, N., Brun, O., Veziris, N., Argemi, X., Roupret, M., Launay, O., Bergeron, A. and Groh, M. (2018). Bacillus Calmette-Guerin infection following intravesical instillation: Does the strain matter? Médecine et Maladies Infectieuses, http://doi.org/10.1016/j.medmal.2018.11.014.
Machado, D., Lecorche, E., Mougari, F., Cambau, E. and Viveiros, M. (2018). Insights on Mycobacterium leprae Efflux Pumps and Their Implications in Drug Resistance and Virulence. Front Microbiol 9, http://doi.org/10.3389/fmicb.2018.03072.
Maitre, T., Robert, J. and Veziris, N. (2018). Introduction: épidémiologie de la tuberculose et de l’infection tuberculeuse latente. Rev Mal Respir 35, 859–861, http://doi.org/10.1016/j.rmr.2018.08.009.
Mieras, L. F., Taal, A. T., van Brakel, W. H., Cambau, E., Saunderson, P. R., Smith, W. C. S., Prakoeswa, C. R. S., Astari, L., Scollard, D. M., do Nascimento, D. C., Grosset, J., Kar, H. K., Izumi, S., Gillini, L., Virmond, M. C. L. and Sturkenboom, M. G. G. (2018). An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++. BMC Infectious Diseases 18, 506, http://doi.org/10.1186/s12879-018-3402-4.
Rueda, D., Bernard, C., Gandy, L., Capton, E., Boudjelloul, R., Brossier, F., Veziris, N., Zimic, M. and Sougakoff, W. (2018). Estimation of pyrazinamidase activity using a cell-free In vitro synthesis of pnca and its association with pyrazinamide susceptibility in Mycobacterium tuberculosis. Int J Mycobacteriol 7, 16–25, http://doi.org/10.4103/ijmy.ijmy_187_17.
Sayes, F., Blanc, C., Ates, L. S., Deboosere, N., Orgeur, M., Le Chevalier, F., Gröschel, M. I., Frigui, W., Song, O.-R., Lo-Man, R., Brossier, F., Sougakoff, W., Bottai, D., Brodin, P., Charneau, P., Brosch, R. and Majlessi, L. (2018). Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein Effectors. Cell Reports 23, 1072–1084, http://doi.org/10.1016/j.celrep.2018.03.125.
Scherr, N., Bieri, R., Thomas, S. S., Chauffour, A., Kalia, N. P., Schneide, P., Ruf, M.-T., Lamelas, A., Manimekalai, M. S. S., Grüber, G., Ishii, N., Suzuki, K., Tanner, M., Moraski, G. C., Miller, M. J., Witschel, M., Jarlier, V., Pluschke, G. and Pethe, K. (2018). Targeting the Mycobacterium ulcerans cytochrome bc 1 : aa 3 for the treatment of Buruli ulcer. Nature Communications 9, 5370, http://doi.org/10.1038/s41467-018-07804-8.
van Ingen, J., Aksamit, T., Andrejak, C., Böttger, E. C., Cambau, E., Daley, C. L., Griffith, D. E., Guglielmetti, L., Holland, S. M., Huitt, G. A., Koh, W.-J., Lange, C., Leitman, P., Marras, T. K., Morimoto, K., Olivier, K. N., Santin, M., Stout, J. E., Thomson, R., Tortoli, E., Wallace, R. J., Winthrop, K. L. and Wagner, D. (2018). Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement. European Respiratory Journal 51, 1800170, http://doi.org/10.1183/13993003.00170-2018.
Walker, T. M., Merker, M., Knoblauch, A. M., Helbling, P., Schoch, O. D., Werf, M. J. van der, Kranzer, K., Fiebig, L., Kröger, S., Haas, W., Hoffmann, H., Indra, A., Egli, A., Cirillo, D. M., Robert, J., Rogers, T. R., Groenheit, R., Mengshoel, A. T., Mathys, V., Haanperä, M., Soolingen, D. van, Niemann, S., Böttger, E. C., Keller, P. M., Avsar, K., Bauer, C., Bernasconi, E., Borroni, E., Brusin, S., Dévis, M. C., Crook, D. W., Dedicoat, M., Fitzgibbon, M., Gagneux, S., Geiger, F., Guthmann, J.-P., Hendrickx, D., Hoffmann-Thiel, S., Ingen, J. van, Jackson, S., Jaton, K., Lange, C., Stalder, J. M., O’Donnell, J., Opota, O., Peto, T. E. A., Preiswerk, B., Roycroft, E., Sato, M., Schacher, R., Schulthess, B., Smith, E. G., Soini, H., Sougakoff, W., Tagliani, E., Utpatel, C., Veziris, N., Wagner-Wiening, C. and Witschi, M. (2018). A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. The Lancet Infectious Diseases 18, 431–440, http://doi.org/10.1016/S1473-3099(18)30004-5.
World Health Organization (2018). Technical Report on
critical concentrations
for drug susceptibility testing
of medicines used in the
treatment of drug-resistant
tuberculosis, WHO, Geneva, URL: https://apps.who.int/iris/rest/bitstreams/1098393/retrieve.